Speakers | Intelligent Health AI | Sept 2020 | Online

Our speakers

 

 

The people shaping the future of AI in medicine

 

 

 

Our brilliant AI in medicine disruptors

DR. ROBERT CALIFF
Former Commissioner FDA & Head of Health and Policy 
Alphabet (Google Health and Verily Life Sciences)
     
DR. ROBERT CALIFF
Former Commissioner FDA & Head of Health and Policy 
Alphabet (Google Health and Verily Life Sciences)
     
JOHN NOSTA
President
NostaLab
         
JOHN NOSTA
President
NostaLab
         

First and foremost, John is a thinker. A thinker entrenched in the world of science, medicine and innovation. John is the founder of NOSTALAB—a digital health think tank. He’s generally regarded as one of the top global strategic and creative thinkers in this important and expanding area. He is also one the most popular speakers around the globe presenting his vibrant and insightful perspective on the future of health innovation.

Unwilling to accept the status quo, he’s a contrarian with a focus the future of health and wellness. A leading voice in the convergence of technology and health, Nosta helps define, dissect and deliberate global trends in digital health. He is consistently ranked among the top names in almost every digital list and has sustained that position for several years. Beyond simply an influencer, John is also defined as “most admired” to “top disruptor” in digital health, life sciences and the pharmaceutical industry. He is also a member of the Google Health Advisory Board and has penned HEALTH CRITICAL for Forbes–a top global blog on health and technology.

John has an established reputation as a vocal advocate for strategic thinking and creativity. He has built his career on the “science of advertising,” a process where strategy and creativity work together for superior marketing. He has also been recognized for his ability to translate difficult medical and scientific concepts into material that can be more easily communicated to consumers, clinicians and scientists. Additionally, John has distinguished himself as a scientific thinker. Earlier in his career, John was a research associate at Harvard Medical School and has co-authored several papers with global thought-leaders in the field of cardiovascular physiology with a focus on acute myocardial infarction, ventricular arrhythmias and sudden cardiac death.

John cut his teeth at the “big” agencies including Ogilvy CommonHealth, where he has held a series of positions including Chief Creative Officer, Chief Strategic Officer and unit President.

 

YAN HUANG
General Manager - Intelligent Healthcare
Baidu
                     
YAN HUANG
General Manager - Intelligent Healthcare
Baidu
                     

Yan has nearly 20 years of experience in the field of machine learning and artificial intelligence, with a focus on R&D, application, management and innovation. She has been the General Manager of Baidu Intelligent Healthcare since 2018. During her role, she has launched the brand “Ling Yi Zhi Hui (Chinese name:灵医智惠) “ with the vision of “Evidence-based AI empowers primary healthcare”.

 

Prior to joining Baidu, she was the Staff R&D engineer at Google in the U.S., where she started her career in 2005.

 

Yan graduated from Georgia Institute of Technology. Yan serves as the Vice Chairman of Intelligent Hospital and Artificial Intelligence Application Working Committee of Chinese Medical Information and big data Association (CHMIA). She also serves as a leading advisory expert of Peking University Medical Science and Technology Innovation Project.

ANN AERTS
Head
Novartis Foundation
         
ANN AERTS
Head
Novartis Foundation
         

The Novartis Foundation focuses on innovating health and care for low-income populations, driven by data, digital and AI. Ann chairs the Broadband Commission for Sustainable Development Working Group on Digital Health, is a member of the International Advisory Board of the Commonwealth Centre for Digital Health. Ann served as a member of the US National Academies of Science Engineering and Medicine Committee on Improving the Quality of Health Care Globally and currently sits on the US National Academies of Medicine Commission on Healthy Longevity.

Before leading the Novartis Foundation, Ann was Franchise Medical Director Critical Care for Novartis Pharma in Basel and Therapeutic Area Head Cardiovascular and Metabolism for Novartis Pharma Belgium. 

Prior to joining Novartis, she served as Director of the Lung and Tuberculosis Association in Belgium and as Head of the Health Services Department of the International Committee of the Red Cross (ICRC) in Geneva. She has also worked as Health Coordinator for the ICRC in several countries.

Ann holds a Degree in Medicine and a Masters in Public Health from the University of Leuven, Belgium, as well as a Degree in Tropical Medicine from the Institute of Tropical Medicine in Antwerp, Belgium. 

 

DR. GREG MOORE
Corporate Vice President 
Microsoft Health
             
DR. GREG MOORE
Corporate Vice President 
Microsoft Health
             

Dr. Moore leads Microsoft’s Health efforts globally and is responsible for product strategy, product development, and research including AI and machine learning technology for healthcare and life sciences. He is also Microsoft’s senior executive leading dedicated research and development collaborations with Microsoft’s strategic alliance partners in this domain with the goal of enabling a more open, interoperable, and AI-infused foundation for healthcare delivery that aspires to enable access to healthcare for all globally.

Greg is an engineer (MIT PhD), practicing neuroradiologist, clinical informaticist, neuroscientist, and innovator experienced in assembling and inspiring highly talented teams to positively transform healthcare for the benefit of humankind. Prior to joining Microsoft, Greg was Vice President Google Inc, Google Cloud Healthcare & Life Sciences and founder of the healthcare vertical for Google Cloud. Prior to his leadership appointment at Google, he was Chief Emerging Technology and Informatics Officer at Geisinger Health System where he also was Director of the Institute for Advanced Application and served as Interim Chair of System Radiology. His prior appointments include Los Alamos National Laboratory (University of California), Wayne State University School of Medicine, Children’s Hospital of Michigan and Penn State University Hershey Medical Center where he was a tenured Professor in the College of Medicine. Greg currently serves on the board Hillrom Inc, and is an Adjunct Clinical Professor of Radiology at Stanford University School of Medicine.

Moore is board certified in Diagnostic Radiology, Neuroradiology and Clinical Informatics and holds degrees from North Park College-Chicago (BS), Massachusetts Institute of Technology (SM-Nuclear Engineering and PhD-Radiological Sciences), and Wayne State University School of Medicine (MD-Doctor of Medicine) and completed residency in Diagnostic Radiology and a fellowship in Neuroradiology, both at Penn State University Hershey Medical Center.

 

DR. FREDDY ABNOUSI
Interventional Cardiologist and Head of Health Technology
Facebook
                 
DR. FREDDY ABNOUSI
Interventional Cardiologist and Head of Health Technology
Facebook
                 

Dr. Abnousi is the Head of Health Technology at Facebook and a practicing Interventional Cardiologist. He also serves as Innovation Advisor to the American College of Cardiology, Professor Adjunct at Stanford University School of Medicine, and Assistant Professor Adjunct at Yale University School of Medicine. He has previously led innovative healthcare efforts at companies such as McKinsey and Google, and has served as Founder and CMO of CorDynamix Inc., an interventional heart failure company. He completed Fellowships in Cardiovascular Medicine and Interventional Cardiology, as well as Residency in Internal Medicine at Stanford University Medical Center. He was previously a resident surgeon at the University of California, San Francisco. He completed his MD at Stanford University School of Medicine, MBA from Oxford University, and MSc in Health Policy, Planning, & Financing from the London School of Economics. 

WENJUN XIE
Head of AI Healthcare Strategy
Tencent
       
WENJUN XIE
Head of AI Healthcare Strategy
Tencent
       
DR. JOHN HALAMKA
President
Mayo Clinic Platform
   
DR. JOHN HALAMKA
President
Mayo Clinic Platform
   
VANESSA CANDEIAS
Former Head, Global Health and Healthcare; Member of the Executive Committee
World Economic Forum
VANESSA CANDEIAS
Former Head, Global Health and Healthcare; Member of the Executive Committee
World Economic Forum

Trained as a nutritionist, Faculty of Nutrition and Food Sciences, Porto University; Master’s in Public Health, London School of Hygiene and Tropical Medicine. Formerly: worked at national level on developing and implementing health promotion policies with the Ministry of Health in Portugal and the Institute of Preventive Medicine of the University of Lisbon; worked with the World Health Organization Headquarters on global guidelines and policy development for noncommunicable diseases. Currently, Head of System Initiative on Shaping the Future of Health and Healthcare and Member of the Executive Committee, World Economic Forum. The System Initiative on Shaping the Future of Health and Healthcare provides a dynamic platform for leading businesses, governments, civil society organizations and world class experts to shape the global health agenda; co-design and accelerate the implementation of collaborative approaches that transform the health ecosystem – across prevention, diagnosis, treatment, cure and maintenance of health; and ultimately enables populations to live healthier lives and have access to the care they need when they need it.

DR. SATCHIT BALSARI
Assistant Professor in Emergency Medicine
Harvard Medical School (Beth Israel Deaconess Medical Center)
 
DR. SATCHIT BALSARI
Assistant Professor in Emergency Medicine
Harvard Medical School (Beth Israel Deaconess Medical Center)
 
DR. SEMA SGAIER
Co-Founder & Executive Director | Surgo Foundation
Adjunct Assistant |Harvard TH Chan School of Public Health 
DR. SEMA SGAIER
Co-Founder & Executive Director | Surgo Foundation
Adjunct Assistant |Harvard TH Chan School of Public Health 

Dr. Sema Sgaier leads Surgo Foundation’s strategy, operations, and partner relations. She works at the intersection of behavior, data, and technology, drawing on her extensive experience in policy, strategy, and management of development programs.  Sema has led several large-scale programs, as well as research and evaluation projects, and has worked with governments in India and Africa on public-health policy and large-scale delivery. 

Prior to joining Surgo Foundation, Sema held several roles at the Bill & Melinda Gates Foundation. She led a portfolio on voluntary medical male circumcision for HIV prevention across eastern and southern Africa. As part of the India Country Office, Sema led the scale-up of the foundation’s HIV prevention program (Avahan) in several states, managed its transition to the government of India, and developed data platforms for decision-making. 

Before joining the Gates Foundation, Sema was a neuroscience and genomics scholar at Harvard Medical School and a fellow with the Centre for Global Health Research. She is an Assistant Adjunct Professor at the Harvard T.H. Chan School of Public Health and an Affiliate Assistant Professor, Global Health at the University of Washington. She also serves on the board of the Bill & Melinda Gates Foundation’s Alumni Network. Sema was selected as a Rising Talent by the Women’s Forum for the Economy and Society.  

Sema received her PhD in cellular and molecular biology (developmental genetics) from New York University, her MA in neuroscience from Brown University, and a BSc in molecular biology and genetics from Boğaziçi University (Istanbul).   

 

ELENA BONFIGLIOLI
Managing Director Health and Life Sciences
Microsoft EMEA
ELENA BONFIGLIOLI
Managing Director Health and Life Sciences
Microsoft EMEA

Elena Bonfiglioli, Managing Director Health and Life Sciences, Microsoft EMEA
Elena Bonfiglioli leads the Health and Life Sciences Industry business for Microsoft in Europe, Middle East and Africa, and is part of the World Wide Commercial Business Team. She is responsible for driving strategy and business development, partnerships, and positioning for the region across public health, social services, providers, and pharma. Elena is an advocate for the transformation of healthcare systems with Cloud and AI.

HUGUETTE DIAKABANA
Co-Founder
African Alliance of Digital Health Networks
HUGUETTE DIAKABANA
Co-Founder
African Alliance of Digital Health Networks
JUNAID BAJWA
Chief Medical Scientist
Microsoft Research
         
 
JUNAID BAJWA
Chief Medical Scientist
Microsoft Research
         
 

Junaid is the Chief Medical Scientist at Microsoft Research and a practising physician in the NHS (the UK’s National Health Service). He was previously the Global Lead for Strategic Alliances and Solutions for the Global Digital Centre of Excellence at Merck Sharp & Dohme, where he led a range of strategic initiatives to improve patient care, including establishment of internal partnerships across the enterprise and external partnerships across the health care ecosystem. He cofounded “VelocityHealth” as Europe’s first prevention focused digital-health accelerator, in partnership with Telefonica, and led his team to deliver the “NHS Testbed” in partnership with Verily Life Sciences (part of Alphabet), which the Health Service Journal recognized as the “Best Pharmaceutical Partnership with the NHS” in 2018.

Previously, Junaid has worked across primary care, secondary care, and public health settings in addition to acting as a payer, and policy maker within the UK, where he specialized in informatics, digital transformation, and leadership. He has consulted for health care systems across the US, Australia, New Zealand, Singapore, and Europe, in addition to being seconded by the NHS to work with IBM. Junaid completed his MBA at the Imperial College Business School in London and has studied health strategy and quality improvement at both Harvard and the Institute of Healthcare Improvement in Boston. Academically, he is a Clinical Associate Professor at UCL (University College London), and Visiting Scientist at the Harvard School of Public Health.

Junaid hopes to bring his clinical, life sciences, and academic experiences together in this new role. He hopes to help healthcare focused teams across Microsoft, unlock the power of technology to help solve the healthcare challenges of today, whilst reimagining a better future for tomorrow.

 

DR. ERIC OERMANN
Director | AISINAI
Instructor of Neurological Surgery, Department of Neurosurgery | Mount Sinai Health System
DR. ERIC OERMANN
Director | AISINAI
Instructor of Neurological Surgery, Department of Neurosurgery | Mount Sinai Health System

Eric Karl Oermann, M.D. is an Instructor of Neurological Surgery in the Mount Sinai Health System and the Director of AISINAI, Mount Sinai’s artificial intelligence research group. He studied mathematics at Georgetown University with a focus on differential geometry. Prior to attending medical school, Dr. Oermann spent six months with the President’s Council on Bioethics studying human dignity under the mentorship of physician-philosopher Edmund Pellegrino, M.D.. Dr. Oermann has won numerous awards for his scholarship including fellowships from the American Brain Tumor Association and Doris Duke Charitable Research Foundation where he was first exposed to neural networks and deep learning. He has published over eighty manuscripts spanning basic research on machine learning, deep learning, and the philosophy of medicine.

As a resident Dr. Oermann was selected as one of Forbes Magazine’s “30 Under 30” for his work in using machine learning to develop prognostic models for cancer patients. Dr. Oermann completed a postdoctoral fellowship at Google (Google Health / Verily Life Sciences). He is interested in weakly supervised learning, reinforcement learning with imperfect information, and in building artificial neural networks that more accurately model biological neural networks (“machines that think like humans”). As a physician, he is also interested in the application of deep learning to solve a wide range of practical problems in the medical sciences for improving clinical care.

 

DR. DIVYA CHANDER
Faculty Chair in Neuroscience & Faculty in Medicine
Singularity University
     
DR. DIVYA CHANDER
Faculty Chair in Neuroscience & Faculty in Medicine
Singularity University
     

Dr. Chander is a physician, neuroscientist, and futurist who trained at Harvard, UCSD, UCSF, and the Salk Institute. She is Chair of Neuroscience and Faculty of Medicine at Singularity University, Visiting Scholar in Medicine at Stanford (where she was on faculty for 8 years), and Senior Non-Resident Fellow at the Atlantic Council GeoTech Center. She has also co-founded and leads 2 companies during the pandemic – Lucidify, a tele-neuroICU platform, and Plexxus, a company building the world’s connected global immune system. Dr. Chander also serves on a NASA-White House task force for COVID19, and both co-chairs and directs the post-pandemic global health initiative for OneShared.World. Her research interests center around mapping human consciousness, how consciousness will be altered by human augmentation, and how mapping consciousness in humans may enable us to recognize it in non-human, intelligent beings (both on and off-planet). In 2004, she was a finalist for astronaut selection, and has since maintained a passion for building medical systems in space to sustain human exploration.

DR. NATALIE BANNER
Understanding Patient Data Lead
Wellcome Trust
DR. NATALIE BANNER
Understanding Patient Data Lead
Wellcome Trust

Dr Natalie Banner is the Lead for Understanding Patient Data (UPD), an initiative hosted at the Wellcome Trust to support better conversations about how patient data is used for care and research. UPD works with patients, charities and health professionals to champion responsible uses of data, feeding into policy development, creating accessible resources and horizon scanning for emerging issues that may affect public confidence in the use of health data. This includes exploring emerging data-driven technologies and how to create the right ethical and governance frameworks for these in healthcare and research. Natalie formerly led Wellcome’s policy work on GDPR and data protection, seeking to ensure UK legislation and regulation creates a supportive, trustworthy environment for health research using patient and health-related data. She was recently named in BioBeat’s “50 Movers and Shakers in BioBusiness” for 2018.

BABITA SHARMA
Television Presenter
BBC
BABITA SHARMA
Television Presenter
BBC

Babita Sharma is a BBC News presenter, regularly seen on the BBC News Channel, BBC World News, and presenting the show Newsday.

 

Babita has presented the finance programme Your Money, and fronts business reports for BBC News. She has also covered economic and political stories from around the world.

DR. SONNY KOHLI
Internal Med/ Critical Care Physician | Oakville Hospital
Assistant Prof (adj.) |McMaster University
Founding Faculty |Singurality University Canada
 
DR. SONNY KOHLI
Internal Med/ Critical Care Physician | Oakville Hospital
Assistant Prof (adj.) |McMaster University
Founding Faculty |Singurality University Canada
 

Dr. Sonny Kohli is a practicing Physician in Internal Medicine and Critical Care and is Faculty at SingularityU Canada as well as McMaster University. In 2008/09, Sonny was a top 40 Astronaut Candidate in the Canadian Space Agency (CSA) recruitment campaign. He is also an alumnus of the International Space University, a trained flight surgeon with the Canadian Forces, and was awarded a CSA scholarship to Johnson Space Center & Wyle Labs. While studying at ISU, he helped deploy the Image Reversal In Space (IRIS) experiment on the International Space Station.

In 2010, while volunteering in post-earthquake Haiti, Sonny experienced first-hand the perils of inadequate health care faced by Earth’s most marginalized peoples. Intrigued by space-age and digital solutions to the world’s health problems, Sonny co-founded Cloud DX to create a fully autonomous ‘digital doctor’ called Vitaliti. Sonny and Cloud DX were bestowed as XPRIZE’s first ever ‘Bold Epic Innovator’ as part of the Qualcomm Tricorder XPRIZE competition.

LETIZIA GIONFRIDA
CEO & Managing Director
Arthronica
 
LETIZIA GIONFRIDA
CEO & Managing Director
Arthronica
 
DR. JAMES KINROSS
Senior Lecturer and Consultant in Colorectal Surgery
St. Mary's Hospital, Imperial College London
 
DR. JAMES KINROSS
Senior Lecturer and Consultant in Colorectal Surgery
St. Mary's Hospital, Imperial College London
 

Dr. James Kinross is a consultant colorectal surgeon, at St. Mary’s Hospital London. His clinical interests are in minimally invasive and laparoscopic surgery for the treatment of colorectal cancer. He also has an interest in surgical nutrition and modulation of the gut microbiota by pro and prebiotics for improved operative outcomes. He was trained in Northwest London, and he was an NIHR Clinical Lecturer in Surgery and an Ethicon Laparoscopic Fellow in Colorectal Surgery. He was awarded a Royal College of Surgeons of England training fellowship during his PhD and he was funded by the Academy of Medical Sciences as an early stage lecturer. He is a visiting Professor at the Royal College of Surgeons of Ireland. He is currently funded by Bowel and Cancer research and the Imperial BRC. You can follow him on Twitter at @bowelsurgeon. 

 

He performs translational research into computational and systems biology in surgery. Specifically, he is involved in clinical trials using intra-operative mass spectrometry (known as Real-time Electrospray Ionisation Mass Spectrometry or REIMS) for improving precision in the surgical treatment of colorectal cancer. This technology is also known as the iknife, and he is working on both surgical and endoscopic applications. Mass Spectrometry Imaging (MSI) is complimentary to REIMS and provides novel insights into tumour biology and tumour phenotypes. Dr. Kinross’s research is establishing if metabonomic approaches such as these can be used for stratifying the treatment of both early and advanced cancers. 

Dr. Kinross also studies the role of the gut microbiome in the aetiology of colon cancer, Crohn’s disease and obesity. This is because intestinal inflammation is a common pathway across all conditions. He is performing clinical research at Imperial College London and at the Royal Marsden Hospital. The aim is to develop novel biomarkers for the early detection of bowel cancer, and to develop novel therapies for its treatment based on a deeper understanding of how the microbiota that reside in the gut influence tumour biology and the response of cancer to treatment. As part of this I collaborate internationally with researchers in the USA and across Europe.

Finally, he has a separate interest in the educational application of virtual worlds and gaming technologies for surgical and medical education. He works as part of a team that is building next generation, immersive simulators for use in major incidents and trauma training.

 

SARAH PORTER
CEO and Founder
InspiredMinds!
SARAH PORTER
CEO and Founder
InspiredMinds!

Sarah Porter has launched 21 b2b and b2c technology products in 11 countries since 1996 and has a renowned reputation for taking ideas from concept to market with subsequent significant growth globally. 

Emerging tech / AI / Medtech / Singularity / existentialism is where her core experience lies and she has over 20 years of commercial experience.

As a board executive for i2i events (parent company The Guardian Media Group / Apax – Ascential – previously Top Right Group) with the specific remit to rapidly grow the business whilst leveraging operational costs and prepare pre IPO. She sat on the i2i mergers and acquisitions committee identifying, analysing and approaching target businesses and accelerated growth by 22% within 12 months.

Achievements include the launch and acquisition of Money2020 – a leading fintech product. This included negotiation, 3 stage due diligence, its subsequent integration, and the long term geo-adaption into a global portfolio worth over $40m. The launch of World Retail Congress in 10 countries, the re-launch of Cannes Lions festival.

Sarah is a regular keynote speaker on start-ups, business and women / equality related issues and is an ambassador for the Royal Marsden where she champions the use of AI tech in oncology advances.

 

OLIVER SMITH
Strategy Director & Head of Ethics
Alpha Health, Telefónica Innovación Alpha
OLIVER SMITH
Strategy Director & Head of Ethics
Alpha Health, Telefónica Innovación Alpha

Oliver Smith is the Strategy Director & Head of Ethics at Alpha Health, the health tech Moonshot of Telefónica Innovación Alpha.

 

Oliver propels Alpha Health’s strategy development, establishing and maintaining strong partnerships to further its mission to deliver breakthrough solutions which address the greatest challenges in the healthcare sector worldwide. In addition, Oliver is the Head of Ethics at Alpha Health, ensuring the total trust of users is at the very centre of the Moonshot’s operations.

 

Prior to joining Alpha Health in 2016, Oliver worked as the Director of Strategy and Innovation at Guy’s and St Thomas’ Charity, Deputy Director of Health and Wellbeing at the Department of Health and as a Policy Advisor to the Prime Minister’s Strategy Unit.

 

DR. SANDIP SARKAR
Consultant Vascular and Endovascular Surgeon
Barts Health NHS Trust
     
DR. SANDIP SARKAR
Consultant Vascular and Endovascular Surgeon
Barts Health NHS Trust
     
DR. ROSHANA MEHDIAN
Registrar Trauma and Orhopaedic Surgeon and Director
Hardian Health
       
DR. ROSHANA MEHDIAN
Registrar Trauma and Orhopaedic Surgeon and Director
Hardian Health
       
DR. JAY MANDREKAR
Professor of Biostatistics & Neurology
Mayo Clinic
   
DR. JAY MANDREKAR
Professor of Biostatistics & Neurology
Mayo Clinic
   

Jay Mandrekar, Ph.D., is the primary statistician for the Mayo Clinic Department of Neurology, and the Divisions of Infectious Diseases and Clinical Microbiology. He is involved in multiple clinical trials, population-based studies and research grants in these areas.

Dr. Mandrekar’s primary research interest is in the application and extension of statistical methods for the evaluation of the quality and domains of clinical teaching, multiple sclerosis and other neurologic diseases, prosthetic joint infections, and assays for viral detection.

 

DR. GABRIEL KRUMMENACHER
Team Lead Data Science
Zuehlke Group
       
DR. GABRIEL KRUMMENACHER
Team Lead Data Science
Zuehlke Group
       

Dr. Gabriel Krummenacher is working as a Data Scientist and Lead of the Data Science Team at Zühlke and has several years of experience in conducting data analytics and machine learning projects. He holds a PhD from the Institute for Machine Learning at ETH, where he worked on scalable methods for large-scale and robust learning, wheel defect detection and sleep stage prediction with deep learning. He received a M.Sc. in computer science from ETH Zurich in 2011. He was a visiting researcher at the NICTA Bioinformatics group in Melbourne and interned in the Trading Technology Team at Axa Rosenberg in San Francisco.

TOMAS DIKK
Lead Data Scientist
Zuehlke Group
       
TOMAS DIKK
Lead Data Scientist
Zuehlke Group
       

Tomas Dikk is working as a Lead Data Scientist at Zühlke Group and has many years of research and industry experience conducting machine learning projects. He holds a Master of Science degree in Computer Science from ETH Zurich with a focus on Machine Learning and was a research associate at the Institute for Machine Learning at ETH Zurich, conducting and publishing research in the area of sparse methods for matrix factorization with applications to speech enhancement and source separation.

ROLAND HERZOG
Head Technology Transfer
AO Foundation
       
ROLAND HERZOG
Head Technology Transfer
AO Foundation
       

Roland is heading the AO Technology Transfer Team. As part of the AO Innovation Translation Center, the Technology Transfer offers inventors and product developers a pathway to move their ideas from paper to patients, which includes funding, knowledge leadership, expert insight, proof-of-concept, clinical validation, and valorization.

Roland has more than 20 years of experience in Medtech in Innovation Management, Marketing and Development. He holds a MSc in Physics and a PhD in Biomechanics from the ETH Zürich.

 

DR. STEFAN GERMANN
CEO
Fondation Botnar
     
DR. STEFAN GERMANN
CEO
Fondation Botnar
     

Stefan Germann is CEO of Fondation Botnar, a large foundation in Basel (Switzerland) focused on child health, nutrition and education. He was formerly Executive Director of onegoal.org (an innovative collaborative child nutrition and healthy lifestyle campaign) and Senior Director of World Vision International’s Sustainable Health Partnership, Innovation and Accountability unit based in Kuala Lumpur, Malaysia.

He has worked for more than 15 years in Africa in different leadership roles with various agencies related to child health development, relief and advocacy work. His worked included managing a large rural hospital in Zimbabwe. He has held a number of board and advisory board memberships (Partnership for Maternal, Newborn and Child Health, UBS Optimus Foundation, REPSSI in Africa) and currently sits on the Advisory Board of the Global Health Program, The Graduate Institute – Geneva focusing on the role of NGOs in global health diplomacy.

He holds a micro-engineering BSc degree, an MSc degree (Economics) in Social Policy & NGO Management and, in 2005, completed a doctoral degree in Development focused on child wellbeing in an urban African context. In 2015, Stefan graduated from the Executive Masters program in Tri Sector Collaboration at Singapore Management University.

 

ELENA VAN DIJK
CEO
CME Swiss
       
ELENA VAN DIJK
CEO
CME Swiss
       

Elena van Dijk, graduated in Biochemistry, extended by 3y scientific study of neurotransmitters at the Faculty of Medicine of the University of Comenius in Bratislava. 5y experience in cancer research at the Children Faculty Hospital in Bratislava. 10y General manager of Teva Pharmaceuticals. From 2013 till now CEO & Owner of Private Clinic EvD in Slovakia/ Belgium/Netherland and CME ITeC sro

SARAH JENNA
CEO & Co-Founder
My Intelligent Machines
       
SARAH JENNA
CEO & Co-Founder
My Intelligent Machines
       

Sarah Jenna is the co-founder and CEO of My Intelligent Machines (MIMs) and also associate professor specialized in genomics and genetics at the Department of biochemistry at UQÀM (unpaid leave from the university). Over the past 20 years, she received her Ph.D. in Cell Biology, Structural Biology and Microbiology from Aix-Marseille University in France, she completed her postdoctoral training in cell signalling at McGill University and was also platform manager at the Montréal Proteomic Network. In 2006, because of her dual expertise in cellular and genomic signalling, she was awarded an NSERC (Natural Sciences and Engineering Research Council of Canada) Junior Canada Research Chair in Integrative Genomics and Cell Signaling at UQAM (Jennasarah.wixsite.com/jennaslab), she co-founded and was the former director of Pharmaqam (pharmaqam.uqam.ca), a university research center focusing on drug development.  She is, still a member of the targets steering committee of the “Réseau Québécois de Recherche sur la Médecine” (RQRM, Rqrm.ca). As a Principal investigator at UQAM, she directed a research laboratory developing new integrative genomics strategies to better understand the functional interactions between genes in model organisms and human in the context of breast cancer. As co-founder and CEO of MIMs, she translates this expertise to provide MIMs clients with cutting edge integrative genomics strategies while paying particular attention to the specific needs of life scientists working in BioPharma, Agritech and research institutes.

ANDRE ESTEVA
Head of Medical AI
Salesforce Research
       
ANDRE ESTEVA
Head of Medical AI
Salesforce Research
       

Andre Esteva is a researcher and entrepreneur in deep learning and computer vision. He currently serves as Head of Medical AI at Salesforce Research.

He obtained his PhD in Artificial Intelligence at Stanford, advised by Sebastian Thrun and co-advised by Stephen Boyd. His research was in deep learning and computer vision, with applications built for dermatology, drug screening, neuroscience, and psychiatry.

Notably, his work showed that computer vision algorithms could match the performance of dermatologists at classifying skin cancer from images. His work has made the cover of Nature, as well as Cell, Nature Medicine, NeurIPS, and other venues. It has been widely covered by the WSJ, Fortune, BBC, The Economist, and similar news outlets. He interned at Google Research, Sandia National Labs, and GE Healthcare.

He finished undergraduate degrees with highest honors in Electrical Engineering and Pure Math from UT-Austin and was awarded Engineering Valedictorian (formally, the Outstanding Scholar-Leader Award).

 

DR. CHRIS BATES
Director of Research
TPP
DR. CHRIS BATES
Director of Research
TPP

Chris is a data scientist and developer at TPP and holds a PhD in Mathematics from the University of Manchester. Chris leads TPP’s work in the use of EHR data to support analytics, research, and surveillance. He has previously been recognised by the Health Service Journal (HSJ) as one of the top 50 innovators in UK healthcare.

In recent years, Chris led the TPP team which contributed to the development of the national Electronic Frailty Index (eFI). He is involved in a number of national research programmes, including in cancer survivorship and antimicrobial resistance. He works closely with the UK Biobank team, helping to combine EHR data with genomic information to support their vital research.

Chris also has a strong interest in clinical terminologies and open standards for interoperability. He has spoken on many digital health topics at large conferences, including at both SNOMED CT Expos and at Health Datapalooza in the US. He is an active researcher and has co-authored a number of academic papers in prominent journals, such as Science.

As part of TPP’s response to the Covid-19 pandemic, Chris has been a key member of the OpenSAFELY collaborative and has helped build a large, secure platform for national Covid-19 research. He is also leading TPP’s support of the PRINCIPLE trial at the University of Oxford, aiming to discover whether selected treatments can improve Covid-19 outcomes.

 

ANTONIO RUSSO
AI, Innovation and Future of Health Lead
Deloitte
       
ANTONIO RUSSO
AI, Innovation and Future of Health Lead
Deloitte
       

Antonio leads Deloitte’s Analytics & Cognitive Advisory in Switzerland and is responsible for Innovation within Deloitte Switzerland’s Executive team. His team helps clients leverage the power of artificial intelligence and data to deliver more customer-centric and innovative products and services that catalyse growth and efficiencies.

He has over 20 years of experience in advising companies in large-scale global transformations, leveraging new delivery models (GBS/SSC, outsourcing) and innovative technologies (e.g. robotics, machine learning, natural language processing/generation). He helps global private sector and financial services organisations review and implement new strategies for business support functions, and deploy more effective and efficient services and governance models. Prior to joining Deloitte in April 2013, he held various sales and consulting leadership positions across Europe and was CEO of a start-up company developing brand protection technologies.

DR. MARCIN PIETRZYK
CEO
Unit8
       
DR. MARCIN PIETRZYK
CEO
Unit8
       

Marcin Pietrzyk is the founder and CEO of Unit8 , the company bringing world-class experts with a proven track record in AI and Software Engineering to solve problems for industries that will experience the most significant breakthroughs in the next 50 years. He was the visiting lecturer at  the University of St Gallen for EMBA and Certificate of Advanced Studies (CAS) in digitalisation. Before that he was the Head of Network Intelligence and then Head of Big Data & BI at Swisscom. He completed his PhD in Orange Labs, Sophia Antipolis, France in the domain of data mining and machine learning in the context of IP networks intelligence.

AVANI TANNA
Data Scientist
International Committee of the Red Cross
AVANI TANNA
Data Scientist
International Committee of the Red Cross
DR. PIYUSH MATHUR
Staff Anesthesiologist and Critical Care Physician | Cleveland Clinic
Co-Founder | BrainX
DR. PIYUSH MATHUR
Staff Anesthesiologist and Critical Care Physician | Cleveland Clinic
Co-Founder | BrainX

Piyush Mathur MD,FCCM is a Staff Anesthesiologist and Critical Care physician at Cleveland Clinic,Ohio with more than 20 years of clinician experience. He has also served in the role of the Quality Improvement Officer and chair,compliance committee, Anesthesiology Institute for the past 9 years.He completed his medical school training in India from Armed Forces Medical College(AFMC,Pune) followed by residency in Anesthesiology and fellowship in Critical Care from Cleveland Clinic.He subsequently completed a one year, quality fellowship at Cleveland Clinic and training in computer programming, machine learning and deep learning.He is the past program director of the anesthesiology critical care fellowship program at Cleveland Clinic.

A recognized leader in critical care, quality, education and artificial intelligence applications in healthcare, he has led many of the local and national programs including serving as the chair of the post-graduate education committee, coding and documentation education committee of the Society of Critical Care Medicine (SCCM).He is currently a member of CPT editorial advisory committee, AMA(American Medical Association) and primary advisor,SCCM.He has focused his research on applications of artificial intelligence(AI) in healthcare for the last many years.He is the founder and team lead of BrainX, one of the 60 teams in round 2 of IBM Watson Artificial Intelligence Xprize. He has also founded one of the largest online group for machine learning in healthcare, BrainXCommunity.He is a leader in quality and patient safety who has innovated and successfully implemented many algorithms and tools in electronic health records such as difficult airway identification(EPIC), anesthesia awareness alert (DSS, Talis), antibiotic alert (ACG, Talis).Recipient of multiple innovation awards at Cleveland Clinic, he is leading innovation efforts in integrating machine learning and artificial intelligence in healthcare. Current, projects include AIDE(Artificial Intelligence Diagnosis Engine), SALUS (robotic artificial intelligence patient safety system),BRAINS(Biologically Relational Artificial Intelligence Networking System).He is a recipient of numerous local and international awards including Institute of Healthcare Improvement(IHI) Permanante award and the prestigious Presidential citation from Society of Critical Care Medicine (SCCM).He has made numerous local, national and international presentations and publications in the fields of anesthesiology, critical care, quality, education and artificial intelligence applications in healthcare.

 

DR. FRED JORDAN
CEO
AlpVision
           
DR. FRED JORDAN
CEO
AlpVision
           

Dr. Fred Jordan is co-founder of AlpVision and has served as CEO since June 2001. He is the author of numerous scientific publications and patents and co-inventor of Cryptoglyph and Fingerprint, AlpVision’s core technologies. Dr. Jordan has work experience in the United States and in France. In 1999, he received his PhD from the Swiss Technology Institute (EPFL) – Signal Processing Institute (ITS) in Lausanne.

LUCY SETIAN
Digital and AI Stakeholder Engagement Lead
Novartis Foundation
             
LUCY SETIAN
Digital and AI Stakeholder Engagement Lead
Novartis Foundation
             

Lucy Setian is responsible for the strategy and implementation of Digital & AI programs at the Novartis Foundation. Lucy is currently working on fostering multi- organizational and governmental dialogue and implementing initiatives based on best practices in digital health care and delivery in low- and middle- income countries.

Prior to joining the Novartis Foundation, she was in charge of the Technology Practice at UCB, driving strategic communications and educational programs on Digital & AI. Throughout her career, Lucy has held different leadership roles with a focus on corporate strategy and business development, digital project and program management, innovation, marketing and communications across different industries.

Lucy is a Computer Engineer from the German faculty program of the Technical University of Sofia and the Technical University of Karlsruhe. She holds a magna cum laude Master degree in Communication Sciences from VUB-Brussels, and an Executive MBA from Solvay Business School.

DR. JACOB LAPORTE
Co-Founder & Global Head
The Novartis Biome
                 
DR. JACOB LAPORTE
Co-Founder & Global Head
The Novartis Biome
                 

Jake LaPorte, PhD, founded and leads The BIOME by Novartis (aka Novartis Biome), the company’s first-ever, externally-branded innovation lab. The BIOME has garnered global recognition for supporting innovative tech and digital health companies and connecting them to Novartis’s vast network of expertise and resources to accelerate solutions that improve and extend patient’s lives. The BIOME has hubs in San Francisco, London, Paris and Hyderabad and is rapidly expanding into other digital innovation communities. Jake was previously Global Head of Digital Development at Novartis and responsible for leading the company’s digital efforts within their Global Drug Development organization. Jake began his career at McKinsey & Company, where he was a leader in their Pharmaceutical R&D practice, during his six-year tenure, developing an expertise in large, complex transformations and innovation. It was on a fateful, extended journey in Asia-Pacific, however, where Jake read Ray Kurzweil’s The Singularity is Near and became captivated by the possibility of digitalizing the Pharmaceutical R&D engine – he has focused his career to the realization of this concept ever since. He co-founded Snapdragon Chemistry, with the Head of the Chemistry Department at MIT, which seeks to enable companies to implement continuous flow chemistry in discovery, development and manufacturing, with the ultimate goal of fully digitalizing chemical synthesis. Most recently, Jake has held various leadership positions at PPD, Inc., where he collaborated with executives to develop and implement C-level, strategic initiatives, including a long-term transformation to create industry-leading approaches to clinical development in key therapeutic areas. Jake completed his Ph.D. in Organic Chemistry from Harvard University, where he was an HHMI doctoral fellow, and received his B.Sc. in Biochemistry and Mathematics, summa cum laude, from the University of Delaware.

EVE LOGUNOVA
Inclusion & Diversity Ambassador
InspiredMinds!
                   
EVE LOGUNOVA
Inclusion & Diversity Ambassador
InspiredMinds!
                   

Eve is the central point of contact in the BeNeLux market for stakeholders and partners of InspiredMinds and World Summit AI, ensuring the highest possible value of the event for the participants as well as overseeing the Diversity & Inclusion agenda.

 

Many people in the global AI & Tech circles know Eve as Women in AI Ambassador (Netherlands) and Diversity & Inclusion activist. She has been working in the Innovation field for more than 15 years supporting the AI and digital transformation at both corporates and startups. Eve is a big fan of adding a human voice to Data, Artificial Intelligence, Cloud, and Internet of Things, and is a strong believer in the power of equality.  In 2019, she initiated the WaiACCELERATE program aimed to bridge the gender gap in the startup ecosystem. There are now 33 women innovators from around the globe participating in WaiACCELERATE to build their own ventures in the fields of AI, Data Science & Machine Learning.

 

She is an entrepreneur and an active member of the global startup community working closely with startup founders as a consultant and a mentor. Also, she often moderates global and local event.

 

In 2019, Eve was moderating our Startup Track at World Summit AI and in 2020, the CyberShark session at Intelligent Health AI.

NEIL DALY
CEO
Skin Analytics
                       
NEIL DALY
CEO
Skin Analytics
                       

Neil started Skin Analytics in 2012, having worked extensively in mobile innovation and strategy consulting for a number of years. He holds a BSc in Physics from the University of Western Australia and an Executive MBA from London Business School.

GEORGE TAKTAK
CEO & Founder
HowMental
                         
GEORGE TAKTAK
CEO & Founder
HowMental
                         

George Taktak is a social entrepreneur, writer and activist known for his work in mental health. George is the founder of How Mental, a community of over 100,000 mental health advocates collaborating to create a healthier planet. He is also the founder of Feeliom, an innovative mobile app evolving the way we communicate emotions through technology to empower proactive mental healthcare.

YUSUKE NAKAMURA
Managing Partner
Plusman
                             
YUSUKE NAKAMURA
Managing Partner
Plusman
                             

Yusuke Nakamura serves as Managing Partner of Plusman. In this capacity, he leads a lot of businesses and manages the company. Before joining Plusman, he has engaged actuarial consulting services for medical device companies, pharmaceutical companies and insurance companies. He holds a Master of Bioengineering from the University of Tokyo and a B.E. from Keio University.

DR. STEPHANIE KUKU
Senior Consultant
Hardian Health
                               
DR. STEPHANIE KUKU
Senior Consultant
Hardian Health
                               

Stephanie is a health technology advisor in digital health and artificial intelligence.  She has over 15 years clinical and research experience and trained and worked in the NHS as a surgical oncologist specialising in women’s cancers.

 

Stephanie is an advisor and consultant in Clinical AI at the World Health Organisation’s Department of Digital Health & Innovation.  She is the Healthcare Lead for Women in AI (WAI), an NHS England Clinical Entrepreneur and Honorary Senior Research Fellow at UCL where she was awarded a Doctorate in Clinical Research.

 

During her clinical career she sat on council of a national cancer society (BGCS) and was awarded numerous International travelling fellowships to; Memorial Sloane Kettering Cancer Center in New York, Cancer Hospital Pernambuco in Brazil, and Centre du Cancer Oscar Lambret in France.

 

Stephanie is a regular speaker on validation of health technology and has hosted a US podcast (HLTH) on themes around technology and the future of health.

GUY HOLMES
President and CEO
Tape Ark
                               
GUY HOLMES
President and CEO
Tape Ark
                               

Guy is the CEO and Founder of Tape Ark, the world’s leading specialist in tape-to-cloud migration. Guy’s enjoyed a 20-year career founding companies in the tape and data management space as well as a successful career in the international oil and gas industry. Prior to entering the oil and gas data management industry Guy was a combat medic and spent five years working at one of Australia’s premier cardiac units in Sydney with renowned transplant surgeons and clinicians.

 

Guy has built a reputation across a wide range of industries for overcoming the issues and complexities of liberating legacy data assets to the cloud, advising on the commercial considerations one should review, commentating on the risk of doing nothing and moving too slow, and how new discoveries can be found from legacy data using AI & ML technologies that add significant value to the utility of data.

 

Guy has a degree in Physics, an MBA in Technology Management and maintains memberships with the ASEG, PESA & the AICD and regularly is a guest speaker and writer for various global industry conferences and publications. He resides in Perth Australia, has been married for 30 years and has five kids.

ANDREW SCHROEDER
Vice President of Research and Analysis
Direct Relief
                               
ANDREW SCHROEDER
Vice President of Research and Analysis
Direct Relief
                               

Andrew Schroeder leads humanitarian research and analysis at Direct Relief, a medical response NGO based in California, focused on connecting the world’s most vulnerable communities with access to essential medicines and medical supplies. He is also the co-founder of WeRobotics, an NGO building partnerships in nearly 30 countries to support localized robotics and AI applications. During the COVID-19 pandemic he co-founded the Covid-19 Mobility Data Network along with Harvard School of Public Health to improve the use of large-scale data on human mobility for infectious disease epidemiology and public health response.

DR. ANURAG AGRAWAL
Director
Institute of Genomics and Integrative Biology at  Council of Scientific and Industrial Research
                               
DR. ANURAG AGRAWAL
Director
Institute of Genomics and Integrative Biology at  Council of Scientific and Industrial Research
                               

Dr. Anurag Agrawal took charge as director of CSIR Institute of Genomics & Integrative Biology (IGIB) on 25th October 2017. He graduated in medicine from the All India Institute of Medical Sciences in 1994, followed by specialization in Internal Medicine, Pulmonary Disease, and Critical Care from Baylor College of Medicine, Houston, (2003) and a PhD in physiology from Delhi University. After serving as a faculty member of the Department of Medicine at Baylor, he joined IGIB in 2007, where he established the Centre of Excellence for Translational Research in Asthma & Lung disease (TRiAL) and the CSIR program for Effective Application of Community Health efforts through new age Information Technology (EACH-IT). His research activities include use of experimental and computational model-systems to study disease, especially asthma. Dr Agrawal believes health data analytics, with artificial intelligence applications, to be the new frontier of medicine and is actively engaged in promoting the confluence of medicine and informatics. He has more than 100 scientific publications, mostly original research findings communicated in high-impact journals. He has been recognized internationally, as an alumnus of Kavli Frontiers of Science program of the US National Academy of Sciences, as well as nationally in the form of the Shanti Swaroop Bhatnagar award (Medical Sciences, 2014), National Bioscience award (2015), Wellcome Trust DBT India Alliance senior fellowship (2015), Lady Tata Young Researcher Award (2010) and the Swarnjayanti Fellowship of the Department of Science and Technology (2010). Dr. Agrawal is a member and fellow of numerous academic societies and serves on advisory bodies at Public Health Foundation of India, Lady Tata Memorial Trust, Centre for Cellular & Molecular Biology, Centre for Brain Research, and Indraprastha Institute of Information Technology, amongst others, as well as an advisor for start up companies and healthcare organizations.

PATTIE GONSALVES
Project Director
Sangath
                                   
PATTIE GONSALVES
Project Director
Sangath
                                   
DR. PATRICE MATCHABA
Group Head of Global Health and Corporate Resposibility
Novartis
         
DR. PATRICE MATCHABA
Group Head of Global Health and Corporate Resposibility
Novartis
         

Patrice Matchaba, M.D., has been Global Head of Corporate Responsibility for Novartis since October 1, 2017.

Dr. Matchaba most recently served as Global Head of the Cardio-Metabolic development unit at Novartis, where he led the global clinical development of the cardio-metabolic portfolio. He joined Novartis South Africa in 2000 as the Country Pharma Organization Chief Scientific Officer. Since moving to Novartis Pharmaceuticals Corporation in the United States in 2002, he has held several roles of increasing responsibility such as Therapeutic Area Head for Immunology and Infectious Diseases; Global Head of Drug Safety and Epidemiology; and Global Head of the Integrated Development Functions and Regions, which include Global Clinical Operations, Global Clinical Submissions, Integrated Information Sciences, Development Informatics, Development Diversity and Inclusion, and all Medical Country Pharma Organization regions.

Dr. Matchaba completed his medical training at the University of Zimbabwe, and is a fellow of the College of Obstetrics and Gynecology South Africa. In addition, he is a graduate of Harvard Business School’s Program for Management Development.

 

FARINA SCHURZFELD
Chief Marketing Officer
Selfapy
                           
FARINA SCHURZFELD
Chief Marketing Officer
Selfapy
                           

Growth strategist Farina Schurzfeld is current Co-founder of Selfapy, an online therapy platform for mental health disorders.

Previously, she was part of Groupon Australia’s founding team, general manager of Airtasker (Sydney and New York) and co-founder of largest co-working space in Sydney TSL (hosting more than 80 startups). Subsequently, she was Head of Business at two companies of Hitfox Group. Coaching founders, she is also mentor for the UNSW (University of New South Wales) startup program. She holds a Master of Arts in International Business and has recently been awarded as top 30 under 30 from Forbes magazine.

 

SIDDARTHA JHA
AI/Digital Program Manager
Fondation Botnar
                   
SIDDARTHA JHA
AI/Digital Program Manager
Fondation Botnar
                   
MARK SAROUFIM
AI Engineer
Graphcore
       
MARK SAROUFIM
AI Engineer
Graphcore
       
DR. BABAJIDE AYINDE
Machine Learning Scientist
EchoNous
       
DR. BABAJIDE AYINDE
Machine Learning Scientist
EchoNous
       
DR. GEMMA GALDON CLAVELL
Founding Partner
Eticas Research & Consulting
           
DR. GEMMA GALDON CLAVELL
Founding Partner
Eticas Research & Consulting
           

Dr. Gemma Galdon-Clavell is a leading voice on tech ethics and algorithmic accountability.

She is the founder and CEO of Eticas Consulting, where she is responsible for leading the management, strategic direction and execution of the Eticas vision. Her multidisciplinary background in the social, ethical and legal impact of data-intensive technology enabled her and her team to design and implement practical solutions to data protection, ethics, explainability and bias challenges in AI. She conceived and architected the Algorithmic Audit Framework technology which now serves as the foundation for Eticas flagship product, the Algorithmic Bias Tracker.

Under Galdon-Clavell’s leadership, Eticas has forged the development of a new market in digital ethics and trustworthy AI, reaching all verticals including social services, healthcare, finance, government, education, cybersecurity and more.

She also serves as a tech ethics adviser at international and national public and private institutions, and is a highly sought-after keynote speaker and media contributor with the mission to shift the way we think about the promise of technology.

LAURENT VANDEBROUCK
CEO
Chronolife
       
LAURENT VANDEBROUCK
CEO
Chronolife
       

Before joining Chronolife, Laurent set up and grew Qualcomm Life in Europe between 2012 and 2018, Qualcomm Life being an enabler and connectivity provider for connected and Digital Health services globally.

Prior to Qualcomm Life, Laurent developed, launched and managed different new businesses and P&L for the enterprise market in B2B mode for leading satellite operators such as Eutelsat and for leading wireless communication technology providers such as Qualcomm.

His expertise is therefore focused on the development and operation of end-to-end services leveraging innovative satellite, cellular, IoT and Cloud based technologies applied to the enterprise market in general and to Digital Health in particular.

 

MARIAM SHOKRALLA
Digital Health Strategist
World Health Organization
       
MARIAM SHOKRALLA
Digital Health Strategist
World Health Organization
       

Mariam Shokralla is a digital health strategist. She is a pharmacist by training and completed her double masters in the UK, France and the Netherlands. Her current expertise is in digital health governance and tech entrepreneurship. She joined WHO/ digital health department in HQ to leverage ethically grounded and equitable digital innovation. She is passionate about Health systems strengthening using mHealth solutions, Healthcare information strategy, digital health literacy, ethical and data governance issues. Previously, she has been working to support the digital health ecosystem in Egypt and MENA region. Prior, she has been working in medical device and software regulations in Egypt and the USA.

GRETCHEN GREENE
Senior Advisor
The Hastings Centre
     
GRETCHEN GREENE
Senior Advisor
The Hastings Centre
     

Gretchen Greene is an internationally recognized expert on face and emotion recognition and AI and AV policy and ethics whose advice to governments has been read in 8,000 cities. She is a senior advisor at The Hastings Center.

Greene is an international AI policy advisor, Yale-trained lawyer, computer vision scientist, autonomous vehicle engineer, and former U.S. national lab mathematician whose broad, multi-industry and government experience includes technical, legal, and policy work for the U.S. government (Departments of Energy, Defense, Justice, and Homeland Security), the British House of Lords, NRDC Asia, and Ropes & Gray.

Greene has written decision-making algorithms for autonomous navigation, terrorist tracking, and Hollywood animation. She has testified at the Massachusetts state legislature and published in machine learning, policy and science journals. She has been interviewed by leading media outlets, including the Economist, the BBC, and Forbes China. Greene’s AI and governance work with government clients, MIT Media Lab, Harvard Kennedy School, Harvard Law School, Harvard Berkman Klein Center, and Partnership on AI has included developing best practices for AI and ethics in government, universities, and industry; advising governments on AI and AV strategy, policy, and risk; and facilitating collaboration across and between governments and diverse stakeholder groups.

Greene is a TAPPs fellow at Harvard Kennedy School’s Belfer Center for Science and International Relations; and founder of Greene Strategy, an AI and AV policy, strategy, and risk consultancy.  Greene is editor and coauthor of Government Briefing Book: Emerging Technologies and Human Rights, which includes 14 contributors from MIT, Harvard, and RightsCon Tunis and is distributed to governments and NGOs in six continents. Greene was a member of the first MIT Media Lab and Harvard Berkman Klein AI and Governance Assembly and was a member of the MIT/Harvard team that created the first adversarial attack on facial recognition APIs. https://equalais.media.mit.edu/

VINCENT KEUNEN
Founder
Andaman7
         
VINCENT KEUNEN
Founder
Andaman7
         

With 20 years of experience in the health IT sector, Vincent has developed numerous systems in Belgium, some of which are still being used by 90% of hospitals in the country. In 2011, Vincent was recognized as national CIO of the year. Andaman7 is his third company.

 

When Vincent was diagnosed with leukemia in 2007, and his 10 year old son was diagnosed with bone cancer 3 months later, he decided to use his software engineering skills to provide all patients with a tool to manage their health information on their smartphone: Andaman7. The tool is associated with a platform to help pharma and medical device manufacturers run clinical trials and engage patients with PRO (Patient Reported Outcomes) and RWD (Real World Data).

 

JOEL MYHRE
Senior Disaster Management Specialist
Pacific Disaster Center
JOEL MYHRE
Senior Disaster Management Specialist
Pacific Disaster Center

From Kabul to Geneva to Palo Alto, Joel K. Myhre has been honoured over his two decades of public policy and advanced ICT experience to help bring advanced humanitarian technology innovations to civil society actors across the Pacific Rim, Europe, North America, Africa, & Central Asia. He has worked with a broad swath of Public Health, Counter-terrorism, Humanitarian and Disaster Response entities, in addition to UN and US DoD engagements throughout the Pacific Rim and Europe.

Having implemented UN, ISO, & US geospatial standards globally. Mr. Myhre’s technical geospatial endeavours include Membership in the Royal Institution of Chartered Surveyors (MRICS), co-founder of the California Homeland Security GIS Working Group (now HIFLD), participant in the Global Healthcare Facility Database Initiative, and GEOINT subject matter expert for both the LA FBI’s WMD effort and the ad hoc WHO Advisory Group on Mass Gatherings.

Recent endeavours have focused on global public health alerting and response (WHO Geneva), EOC interoperability in Afghanistan, and use of satellite / mobile / UAV data sources for crisis response. He currently serves as the Geneva engagement lead for the Pacific Disaster Center to liaise with UN, WHO, NGO partners globally v a v COVID19 and all-hazards / DRR.

DR. AMRITA KUMAR
Consultant Radiologist & AI Clinical Lead
Frimley Health NHS Foundation Trust
DR. AMRITA KUMAR
Consultant Radiologist & AI Clinical Lead
Frimley Health NHS Foundation Trust

Dr Amrita Kumar is a Consultant Radiologist at Frimley Health NHS Foundation Trust, with a sub-specialist interest in breast cancer screening. She is leading trust wide research collaboration to implement novel artificial intelligence software for improved patient outcomes. She has been appointed as AI Clinical Lead and is responsible for implementation and adoption of Artificial Intelligence practice within the Trust, working in conjunction with various stakeholders with a mission statement of patient-focused value-based healthcare.

PANKAJ GUPTA
Managing Partner
EthAum Venture Partners
             
PANKAJ GUPTA
Managing Partner
EthAum Venture Partners
             
DALITH STEIGER-GABLINGER
Co-Founder and Managing Partner
SwissCognitive AI-HUB
             
DALITH STEIGER-GABLINGER
Co-Founder and Managing Partner
SwissCognitive AI-HUB
             
DR. SATISH MELWANI
Communication Lead
Young Experts Tech 4 Health (YET4H) Council
         
DR. SATISH MELWANI
Communication Lead
Young Experts Tech 4 Health (YET4H) Council
         

Dr. Satish Melwani is a dentist from India, a public health graduate from Melbourne and currently pursuing his PhD in Public Health (Maternal and Child health literacy). He is passionate about improving global health outcomes and drive health equity to leave no one behind. His area of interest is identifying and implementing innovative solutions to enhance health literacy throughout the life course to accelerate prevention and control of Non-Communicable diseases (NCDs) and have worked around the same with the World Health Organisation headquarters in Geneva. Presently, he is Communication Lead for the Young Experts Tech 4 Health (YET4H) council. YET4H is a youth led global council formed to provide independent insight and counsel to Digital Transformation for Universal Health Coverage 2030, a global coalition on leveraging digital innovation to achieve quality healthcare for all. Alongside Fondation Botnar, the founders of the coalition include Partnership for Maternal, Newborn & Child Health (PMNCH), PATH and Women Deliver.

DR VIBHOR GUPTA
Director and Founder
Pangaea Data
         
DR VIBHOR GUPTA
Director and Founder
Pangaea Data
         

Dr. Vibhor Gupta is the founder of Pangaea Data Limited, which is headquartered in London and provides a machine learning based software product to help clinicians and scientists find more patients including those who are undiagnosed with high precision. This is based on Pangaea’s work to extract phenotypes (clinical characteristics and symptoms) from unstructured notes which are part of electronic health records. Vibhor has a breadth of experience in life sciences through his work in industry and academia over the last two decades. Prior to Pangaea, Vibhor started and built the European business for Quantum Secure, which was an enterprise software solutions provider headquartered in Silicon Valley and was successfully acquired by a global corporation in 2015. Following his work at Quantum Secure, Vibhor served as a Senior Vice President of Commercial Strategy and Sales at Seven Bridges Genomics, which was founded at Harvard and provided a cloud based bioinformatics platform. Vibhor has also worked as a management and technology consultant for Deloitte. Vibhor’s academic career focused on conducting molecular biology studies and building bioinformatics tools and machine learning models with epigenetic, genomic, transcriptomic and clinical trial data in the context of oncology and infectious diseases. Vibhor has access to an extensive global network in the Life sciences industry and is regularly invited to speak at international conferences, government funded programs and investment summits.

HUW JONES
Founder and Executive Director
the Virtual Doctors
           
HUW JONES
Founder and Executive Director
the Virtual Doctors
           

Huw has over 25 years’ experience working in Africa. He was a professional safari guide for many years, and subsequently worked in rural development and education e-learning development. He also consulted for the UN in Maastricht and for local government in Norfolk, UK.

Huw is a Fellow of the Royal Geographical Society and holds an MSc in Environment and International Development from the University of East Anglia.

 

DR. JEAN-PAUL DYM
Medical Director
Nines
             
DR. JEAN-PAUL DYM
Medical Director
Nines
             

Dr. Jean-Paul (JP) Dym is a board-certified and neuroradiology CAQ-certified radiologist and medical director of Nines Radiology, a first-of-its-kind cloud radiology practice, where he oversees the clinical practice and the relationships with Nines healthcare provider clients. JP graduated from Georgetown Medical School, completed his fellowship training at Yale New Haven University Hospital and completed his radiology residency at Lenox Hill Hospital in New York City. Prior to joining Nines, JP was Medical Director and member of the quality assurance team for vRad. As an expert in analyzing misdiagnosed studies, JP has lectured extensively regarding medical missed findings and errors. He currently holds 29 state medical licenses and is on staff at over 500 hospitals throughout the United States. His fields of expertise include all stroke imaging, trauma, tumors, and degenerative diseases.

JP) Dym is a board-certified and neuroradiology CAQ-certified radiologist and medical director of Nines Radiology, a first-of-its-kind cloud radiology practice, where he oversees the clinical practice and the relationships with Nines healthcare provider clients. JP graduated from Georgetown Medical School, completed his fellowship training at Yale New Haven University Hospital and completed his radiology residency at Lenox Hill Hospital in New York City. Prior to joining Nines, JP was Medical Director and member of the quality assurance team for vRad. As an expert in analyzing misdiagnosed studies, JP has lectured extensively regarding medical missed findings and errors. He currently holds 29 state medical licenses and is on staff at over 500 hospitals throughout the United States. His fields of expertise include all stroke imaging, trauma, tumors, and degenerative diseases.

MATEJ MACAK
Associate Principal
QuantumBlack
                 
MATEJ MACAK
Associate Principal
QuantumBlack
                 

Matej Macak is an Associate Partner at QuantumBlack and he specialises in pharmaceuticals and healthcare advanced analytics projects. He is one of the leaders of the practice that focuses on real-world evidence projects. For the past 3 years, Matej has led projects that delivered machine learning analysis of drug efficacy and risk assessment for rare and common diseases using novel data sources. He also leads the data and analytical strategy assessment methodology for real-world evidence and new forms of data. Matej has a PhD in Neuroscience from UCL and a background in data science and machine learning.

DR. JASMINE QIU
Assistant Director - Venture Building
SGInnovate
                 
DR. JASMINE QIU
Assistant Director - Venture Building
SGInnovate
                 

Jasmine Qiu is a General Surgeon by training with three years’ medical residency. Prior to joining SGInnovate, Dr Qiu had gained over seven years commercial experience assuming a wide range of responsibilities including pharmaceutical marketing, supply chain management, operations and business development.  As a part of SGInnovate Venture Building team, she is the Project Lead for a National Research Foundation Central Gap Fund project “Product Development and Verification of a Revolutionary Solution for the Treatment of Glue Ear”, leading the activities in the areas of product development, manufacturing, clinical, quality and regulatory, commercialization roadmap formulation and implementation and equity fundraising. She has also had more than three years’ experience in venture investments in MedTech and Healthtech, working with clinician innovators and entrepreneurial scientists. Dr Qiu holds a degree of Master in Business Administration from Nanyang Technological University, Singapore. She cleared all three Chartered Financial Analyst exams in three consecutive years.

JOSEPH MOCANU
Managing Partner
Verge Health Tech Fund
                   
JOSEPH MOCANU
Managing Partner
Verge Health Tech Fund
                   
NAVJEEWAN KHOSLA
Director
Quadria Capital
                   
NAVJEEWAN KHOSLA
Director
Quadria Capital
                   
COURTNEY COLE
Founder and CEO
ForaHealthyMe
                 
COURTNEY COLE
Founder and CEO
ForaHealthyMe
                 

ForaHealthyMe develops and licenses a suite of Remote Care Virtual Solutions. ForaHealthyMe’s solutions equip health providers with tools including telehealth & tele-rehab technology to support patient care across a variety of chronic, acute and mental health care issues.
 

Over the past four years, Courtney has collaborated with institutions like Toronto Rehab Institute, Spinal Cord Injury Ontario, Lawson Health Research Institute, the Center for Addiction and Mental Health (CAMH), York and McMaster Universities and the University of Toronto.  

The results of research and development projects includes multiple publications in international academic journals, including poster presentations at the Canadian Society for Vascular Surgery Poster Presentation (2015 Conference), The International Society for Posture & Gait World Congress July, 2019 and the Journal of Medical Internet Research – Mental Health.

In August, 2020, ForaHealthyMe Inc. was featured among partners in a Microsoft tribute video during its Canada Awards Celebration. The video showcased how Canadians and partners in healthcare, among other sectors, responded during the challenges faced during the COVID-19 crisis.  

In his role, Courtney is recognized as a leader and innovator in the Canadian health technology ecosphere.

He has been part of both Government of Canada and the Government of Ontario delegations to international conferences and trade shows where at times, he has served as a panellist and presenter.

GRACE CASTILLO-SOYAO
Founder and CEO
Self Care Catalysts
             
GRACE CASTILLO-SOYAO
Founder and CEO
Self Care Catalysts
             

Founder, Chief Executive Officer of Self Care Catalysts, a patient-driven Digital Therapeutics, data, intelligence, analytics company. An Entrepreneur with the heart and resolve to solve human – centered problems. A big proponent of Citizen Science. Currently building and growing a team of technologists, patient advocates, healthcare informatics and data scientists to put patients at the center and intersection of human networks, technology and science.

Her leadership and over 25 years of corporate experience are significant pillars to the success and innovative transformation of Self Care Catalysts Inc., a patient-driven digital Therapeutics, research and analytics and company.

Leveraged her extensive experience in  strategy, new product launches, designing business models, commercial marketing, patient research experience from consumer packaged goods, consumer healthcare and pharmaceuticals to build a new self care platform for people to drive their health future through data and intelligence.

 

FLORENT BOUGUIN
Vice President - Chief Technology Officer
Optel Group
           
FLORENT BOUGUIN
Vice President - Chief Technology Officer
Optel Group
           

 

Florent Bouguin is Vice-President and Chief Technology Officer at Optel Group a leader company that deploys end-to-end traceability, collects, connects and leverages granular data at every step of the supply chain.

OPTEL’s goal is to create a better world through its innovative traceability technologies. Its Intelligent Supply Chain® (ISC) platform provides the transparency to companies that need to secure their supply chains, optimize their performance, earn customer trust and work together globally to make this goal a reality.

After graduating from Polytechnique (Orleans, France) and completing graduate studies in Laval University (Quebec, Canada), Florent worked as a system engineer for ABB in the space industry. Holding several technical and management roles for 15 years, he contributed to develop spaceborne analysers for green house gas observation, weather forecast prediction and ozone measurement. He joined Optel group a B-Corp certified organization in 2016 as vice president engineering and operations, where he participated to the growth of the business in the life science industry. Currently Chief Technology Officer, Florent drives the technology direction of Optel group to share the corporate vision: A connected world of digital supply chains that provide transparency and optimized performance; and practicing and encouraging social and environmental responsibility and accountability.

PIERRE-ALEXANDRE FOURNIER
Co-Founder and CEO
Hexoskin
     
 
PIERRE-ALEXANDRE FOURNIER
Co-Founder and CEO
Hexoskin
     
 

Pierre-Alexandre Fournier is CEO and co-founder of Hexoskin, a Montreal-based company focused on clinical-grade wearable sensors and AI software for health and clinical research. Hexoskin was founded in 2006 and launched in 2013 the first iPhone compatible smart clothing for health monitoring, which won several international awards. In 2018 Hexoskin launched a remote health monitoring system for astronauts to the International Space Station. The Hexoskin data collection and analytics platform has been used in more than 100 scientific publications. Pierre-Alexandre is also an advocate for transparency in healthcare, patient empowerment, and healthcare innovation through design.

STEFANO PACIFICO
Co-Founder and CEO
Epistemic AI
     
 
STEFANO PACIFICO
Co-Founder and CEO
Epistemic AI
     
 
PRASHANT WARIER
Co-Founder and CEO
Qure.ai
       
 
PRASHANT WARIER
Co-Founder and CEO
Qure.ai
       
 

Prashant Warier is Co-Founder and CEO of Qure.ai, a leading Artificial Intelligence company in Radiology. He is an expert in the field of artificial intelligence and machine learning and has architected and commercialized several AI solutions during his career. His work has been published in journals such as The Lancet and Nature. He is passionate about using AI and machine learning to make healthcare affordable and accessible. Prashant is an evangelist for the adoption of AI in radiology and has given multiple TedX talks, including one at the largest TedX event in the world in Mumbai.

In the past, Prashant was Chief Data Scientist at Fractal.ai and also founded AI-powered advertising technology startup Imagna which was acquired by Fractal.ai in 2015.

JOHANNES BOCH
Director of Access & Urban Health
Novartis Foundation
         
 
JOHANNES BOCH
Director of Access & Urban Health
Novartis Foundation
         
 

Johannes is the Director of Access and Urban Health at the Novartis Foundation.
His responsibilities encompass managing the urban health portfolio of the Novartis Foundation as well as leading global initiatives on innovation in data collaboration, policy and health tech. Johannes contributes to making healthcare systems more resilient through public-private partnerships, engaging entrepreneurial initiatives and supporting innovation in care delivery models, data analytics and technology.
Prior to joining the Novartis Foundation, Johannes worked at the University of St. Gallen (HSG) Institute of Management Latin America in São Paulo, establishing and managing consulting and research activities on impact investing for investors and entrepreneurs, with a focus on healthcare. In addition to assignments with the KfW banking group, Johannes worked as an consultant for companies interested in creating social value while securing financial return.
Johannes has worked as a psychologist in different research and in-/out-patients facilities across Europe. He holds a B.Sc. and a M.Sc. in Psychology from the University of Fribourg (CH), as well as a B.A. in International Affairs from the University of St. Gallen (CH).

SAM KALDAWI
CTO
Vezeeta
         
 
SAM KALDAWI
CTO
Vezeeta
         
 
DR. ANNA WINTERS
CEO
Akros
         
 
DR. ANNA WINTERS
CEO
Akros
         
 

Dr. Anna Winters is the co-founder and CEO of Akros (www.akros.com) and leads a consortia of partners as they build the open-source spatial intelligence platform, Reveal. Anna trained as a spatial epidemiologist in the USA through the US Centers for Disease Control and Prevention’s Fellowship at the Arthropod Infectious Disease Laboratory during her MS and PhD as well as the Centers for Disease Control and Prevention’s Division of Vector-Borne Disease. She worked in Latin America, then transitioned to Zambia for 11 years building the team at Akros, which continues to lend technical support for disease surveillance and response systems to Ministries of Health across southern, central and west Africa. Anna’s interest is to apply the power of spatial intelligence to optimize health interventions and bring equity to health service delivery.

TWITE MULUNDA
MPH- Polio Programs Lead
McKing Consulting
         
 
TWITE MULUNDA
MPH- Polio Programs Lead
McKing Consulting
         
 

Twite (pronounced twee-tay) Mulunda is a Team Lead and a Project Coordinator for the international programs at McKing Consulting Corporation, in Atlanta Georgia. Twite’s work is focused on polio outbreak response activities. As Team Lead, she supports the coordination of McKing consultants working under the direction of the Africa Rapid Response Team for the eradication of circulating vaccine-derived poliovirus 2 (cVDPV2). Her role as a Project Coordinator is a unique project that allows her to work with McKing’s sister organization, the Center for Advancing Public Health, and collaborate with partner organizations implementing on-the-ground initiatives South Sudan. Her current project with the Center for Advancing Public Health focuses on community-based surveillance in an effort to locate acute flaccid paralysis cases that fit the criteria of polio cases, in the Greater Upper Nile region of South Sudan.

 

A citizen of the Democratic Republic of Congo(DRC), Twite holds two bachelor degrees, in Biology and French, from the University of Colorado Denver, and a Master of Public Health from Mercer University in Atlanta, Georgia. Twite’s public health journey started when she got certified to be an HIV tester and counselor at a local organization in Atlanta. She moved on to work at the Centers for Disease Control and Prevention (CDC), on the policy team in the Division of Emergency Operations. After receiving training in emergency management, CDC deployed Twite to Guinea, West Africa to support the Ebola outbreak response. Once Guinea was declared Ebola free, Twite retuned to DRC where she was appointed as a special advisor to the Minister of Health. Once her tenure as advisor  ended, she joined the surveillance team of the Expanded Program on Immunization where she focused on measles, yellow fever and polio surveillance. Her first assignment at McKing, upon returning to Atlanta from the Democratic Republic of Congo included working as a consultant and team member of the Lake Chad Task Team, directly coordinating consultants in security-compromised areas, in efforts to detect and eradicate polio. 

 

DR. NIYI OSAMILUYI
Founder and CEO
Premier Medical Systems (PMS)
         
 
DR. NIYI OSAMILUYI
Founder and CEO
Premier Medical Systems (PMS)
         
 
DR. ISMAIL D BADJIE
Founder and CEO
InnovaRx Global Health
         
 
DR. ISMAIL D BADJIE
Founder and CEO
InnovaRx Global Health
         
 
NENEH SALLAH
Medical Research Scientist
UCL Institute of Health Informatics
         
 
NENEH SALLAH
Medical Research Scientist
UCL Institute of Health Informatics
         
 
DR. OJWANG ALICE ACHIENG
Nutrition and Dietetic Faculty
The Technical University of Kenya
         
 
DR. OJWANG ALICE ACHIENG
Nutrition and Dietetic Faculty
The Technical University of Kenya
         
 
VICTORIA MACDONALD
Health and Social Care Editor
Channel 4 News
         
 
VICTORIA MACDONALD
Health and Social Care Editor
Channel 4 News
         
 

Victoria Macdonald is an award-winning journalist, who has been covering health and social care issues for Channel 4 News since 1999.

She reports on changes in the NHS – the reforms and the politics – whether it is in hospitals or in the community or, indeed in Westminster.

She closely follows the care system and how it impacts on the elderly and those with disabilities as well as investigating issues, including mental health, HIV/Aids and TB, and child health.

Victoria is originally from New Zealand and worked for the Sunday Telegraph before joining Channel 4 News.

BONIFACIA AGYEI
Country Director of SafeCare, PharmAccess Ghana
PharmAccess Group
         
 
BONIFACIA AGYEI
Country Director of SafeCare, PharmAccess Ghana
PharmAccess Group
         
 

As highly skilled assessor and quality improvement facilitator, Bonifacia Benefo Agyei works passionately with healthcare facilities to support improvement in healthcare quality and patient safety using her rich experience in healthcare system management from both public and private sectors. Bonifacia advocates for healthcare quality improvement in Ghana using international quality standards and digital innovations. 

Bonifacia has been working at PharmAccess since 2012 where she currently leads and manages the entire SafeCare Program and other quality related programs provided by PharmAccess Ghana. Among others, this includes directing and coordinating all quality and technical services, while collaborating with public and private partners to support the institutionalization of quality improvement and the digitalization of healthcare in Ghana. She has a range of healthcare management experience, in quality improvement, business development as well as in the development and roll-out of digital innovations.

Prior to joining PharmAccess, she served as Accreditation Quality Officer and Clinical at the National Health Insurance Authority (NHIA), Ghana after almost ten years of experience serving in various nurse management roles and responsibilities in public and private health facilities. She also has extensive experience in training, mentoring, development of quality standards, manuals and curriculum; such as for the novel maternal healthcare franchise network (Woman360) in Ghana. Among other qualifications, Bonifacia holds a bachelor’s degree in nursing, a master’s degree in public administration and is a Fellow in the International Society for Quality in Health Care program (ISQua).

HILA AZADZOY
Managing Director, Global Health Initiative
Ada Health
         
 
HILA AZADZOY
Managing Director, Global Health Initiative
Ada Health
         
 

Hila leads our Global Health Initiative to improve access to healthcare in resource-limited countries. Before Ada, Hila was a founding member and Head of Academics at Kiron Open Higher Education. She is a Digital Female Leader Award recipient, an MIT Solve Member, and a talented public speaker (TEDx, Clinton Global Initiative, UNESCO NGO Forum). “I am dedicated to using technology for social good.”

DR. HELMI ZAKARIAH
CEO
AIME Artificial Intelligence in Medical Epidemiology
         
 
DR. HELMI ZAKARIAH
CEO
AIME Artificial Intelligence in Medical Epidemiology
         
 

Dr Helmi Zakariah (MD, MPH) is currently the CEO of AIME and AI4Good, and a member of the WHO/ITU Working Group for AI in Outbreak. When the Covid19 pandemic reached Malaysia, he was tasked to lead the Digital Epidemiology portfolio for the Selangor State Task Force for Covid19 – the most densely populated state in Malaysia, where he pioneered the nation’s first e-tracing ecosystem and IRC (Inherent Risk of Contagion) Modelling for outbreak containment.

He regularly share his thought in global health platform such as the Chatham House, World Economic Forum, and Commonwealth Digital Health Forum.

MATTHEW PETERS
Head of Investment
Embassy of Canada in Bern
         
 
MATTHEW PETERS
Head of Investment
Embassy of Canada in Bern
         
 

Matthew Peters is Head of Investment at the Canadian Embassy in Bern, Switzerland, a position he assumed in 2018. In this role, Matthew specialises in supporting the Foreign Direct Investment strategies of Swiss and Liechtenstein companies towards Canada. Prior to this he was, Director of Board and CxO Programmes at Deloitte in Switzerland having been Head of Trade and Investmentat the British Embassy in Bern since 2010.

He began his professional career with Nortel Networks in the UK where he was responsible for the mechanical structures in the access multiplexer portfolio. He later became responsible for the optical telecommunications portfolio at Ascom Transmission in Switzerland. Subsequently, he became responsible for the SIM card management platform at SICAP a subsidiary of Swisscom. Matthew Peters holds a BEng (Hons.) in Electronic Engineering with Business Management from the University of York in the UK. He is an electronic engineer by training.

SUE PAISH
CEO
Canada’s Digital Technology Supercluster
         
 
SUE PAISH
CEO
Canada’s Digital Technology Supercluster
         
 

Sue is the CEO of Canada’s Digital Supercluster where organizations from across
Canada come together to solve some of society’s and industry’s biggest problems.
Bringing together industry, researchers and government partners, the Supercluster
drives the development, deployment and scaling of Canadian made digital technologies
while helping small companies scale, large organizations nimbly deploy digital solutions
and researchers bridge the gap to commercialization. The Supercluster is: speeding up
cancer diagnosis times so that patients get diagnoses in days rather than months,
protecting fresh-water lakes, rivers and streams through a data platform that measures
and manages these precious resources, and using data to predict extreme weather
events. These are just a few of the over 60 projects deployed in the past two years.
Prior to the Supercluster, Sue led organizations through material change. While
Managing Partner of Fasken, the firm grew from one office to nine offices on three
continents, while CEO of Pharmasave, the organization pioneered industry leading
technologies for online medication management, and while CEO of LifeLabs, Sue led
material growth while introducing online access to test results and pre-natal genetic
testing. With the Supercluster, Sue continues to drive business growth and Canada’s
global competitiveness through the Supercluster’s collaborative innovation model,
creating digital solutions better than any single organization could develop on its own.
Sue also is the Chair of the Board of CORIX Group of Companies, and Canexia Health
(previously Contextual Genomics), past Chair of the Business Council of British
Columbia and a Director on the Board of Own the Podium. She is a member of the
Advisory Board for Stemcell Technologies, the Expert Panel on Housing Supply and
Affordability and the Government of Canada’s COVID 19 Supply Council.
Sue’s most cherished moments are those spent exploring BC’s remarkable remote
wilderness with her husband, three daughters and her granddaughter.

DR. ALISON DARCY
Founder and President
Woebot Health
         
 
DR. ALISON DARCY
Founder and President
Woebot Health
         
 

Alison is a clinical research psychologist and health tech visionary dedicated to creating smart, scalable and accessible mental healthcare solutions. Her work to explore how digital treatments can help solve human problems began more than 20 years ago, when she created one of the first online support groups for people with eating disorders.

That work led to PhD level studies in psychology at University College Dublin and post-doctoral training at Stanford School of Medicine and with the American Psychiatric Association. At Stanford, Alison also worked with AI pioneer Andrew Ng to explore the intersection of AI and healthcare, leading his Health Innovation Lab in Computer Science.

A frequent speaker on digital therapeutics design and development, barriers to care, and engagement, Alison has authored more than 40 publications and been awarded research grants and contracts from the NIH, the Davis Foundation and APA. She is also currently an Adjunct Lecturer in the Psychiatry and Behavioral Sciences Department of Stanford’s School of Medicine. Alison holds a PhD, an MLitt and a Bachelor of Arts degree in psychology from University College Dublin.

ROBERTO LOTUFO
Founding Partner and CTO
NeuralMind
         
 
ROBERTO LOTUFO
Founding Partner and CTO
NeuralMind
         
 

Roberto A. Lotufo is the CTO co-founder of NeuralMind. He received the B.S. degree from Instituto Tecnologico de Aeronautica, Brazil, in 1978, and the Ph.D. degree from the University of Bristol, U.K., in 1990, in Electrical Engineering. He is a full professor collaborating at the School of Electrical and Computer Engineering, University of Campinas (Unicamp), Brazil, were he has worked for since 1981. His principal research interests are in the areas of Deep Learning for Image and Document Processing and Analysis.

He was the Executive Director of the Inova Unicamp Innovation Agency for ten years. He was awarded the Innovation Personality in 2008 and the Zeferino Vaz Academic Recognition in 2011 from University of Campinas. Member of the winning team of the 2015 Fingerprint Liveness Detection Competition and of the 2020 Use of AI algorithms for the diagnosis of COVID-19 using CT and chest x-ray images.

RAMATOULIE JALLOW
Connector and Administrator
Pan African Women in Health
         
 
RAMATOULIE JALLOW
Connector and Administrator
Pan African Women in Health
         
 

Ramatoulie is a Public Health Consultant and Health Communications Specialist. She holds an MPH in Community Health Promotion, with an interdisciplinary concentration in Global Health, from the University of Minnesota, USA. Ramatoulie is a Connector and Administrator for the Pan African Women in Health (PAWH) virtual platform which creates a space for African women health professionals to connect and provide or receive mentorship.

Presently, she works as a Stigma Index Researcher with the Global Network for People living with HIV (GNP+). Previously, she served as an Epidemiologist, with the US Centers for Disease Control and Prevention, conducting surveillance of the West Africa Ebola outbreak in Guinea and providing technical assistance to the Ministry of Health and to the Expanded Program of Immunization’s supplemental immunization activities for polio eradication. Prior to joining CDC, she conducted HIV/AIDS research in Kigali, Rwanda, as a Global Health Corps fellow, and worked as an HIV/AIDS Medical Case Manager in Minnesota, USA. As a Consultant, she has worked on a variety of projects related to women’s empowerment and the demographic dividend in the Sahel as well as on youth access projects and family planning services in Senegal. Ramatoulie is an avid mentor and an advocate for girls and women’s sexual and reproductive health rights. She is also a member of Scientists of the Gambia, Paradise Foundation’s COVID-19 Coordination team, and EyeToo; initiatives founded by young Gambians, both in the diaspora and at home, to encourage more youth to pursue STEM careers, improve health messaging around COVID-19, and to address accessibility and affordability of vision care in The Gambia, respectively. She is presently based in Yaoundé, Cameroon.

DR. ROOPA DHATT
Executive Director & Co-Founder
Women in Global Health
         
 
DR. ROOPA DHATT
Executive Director & Co-Founder
Women in Global Health
         
 

Dr Roopa Dhatt is a passionate advocate for gender equality in global health and a leading voice in the movement to correct the gender imbalance in global health leadership. Determined to build a movement to transform women’s leadership opportunities in health, Dr Dhatt co-founded Women in Global Health in 2015.

Today, Women in Global Health has more than 25,000 supporters in more than 90 countries and continues to grow. Dr Dhatt, the Executive Director, and the global team work with a network of WGH chapters in every region to challenge power and privilege for gender equity in health by mobilizing a diverse group of emerging women health leaders, by advocating to existing global health leaders to commit to transform their own institutions, and by holding these leaders to account.  With more than 15 chapters in all regions, Women in Global Health is changing the conversation about women’s leadership in health at global, national and local levels.

Dr Dhatt is particularly committed to addressing issues of power, privilege, and intersectionality that keep many women from global health leadership roles and to opening up spaces for the voices of these women to be heard. Women in Global Health’s flagship Heroines of Health event provides a platform for women from diverse backgrounds to share their stories and to advance their leadership. As Co-Chair of the Gender Equity Hub in the Global Health Workforce Network, Women in Global Health published Delivered by Women, Led by Men which looking collectively for the first time at issues of leadership, decent work free from all forms of discrimination, harassment, including sexual harassment, the gender pay gap, and occupational segregation—across the entire health workforce. In recognition of her work advancing gender equality in health, Dr Dhatt was recognized in the Gender Equality Top 100, the most influential people in global policy 2019.

Dr Dhatt is a regular speaker at global health events and has published her views on gender equality widely, including in the Lancet. Dr Dhatt also serves on several advisory bodies advancing gender equality in health, President Council of PathFinder International, Ambassador for Intelligent Health (AI) Conference, the Strategic Advisory Committee for the Global Health Workforce Network (GHWN), and GlobeMed Advisory Board. She was formerly on the Research in Gender and Ethics (RinGS) Advisory Board, Global Health 50/50 Advisory Council, the Global Health Council Advisory Council, and Women Leaders in Global Health Conference Steering Committee in 2017 and 2018. She has led global campaigns relating to the health Sustainable Development Goals (SDGs), health and climate change, the social determinants of health, and Universal Health Coverage (UHC), engaging people from more than 120 countries.

CAITLIN PLEY
Policy Associate
Women in Global Health
         
 
CAITLIN PLEY
Policy Associate
Women in Global Health
         
 

Caitlin Pley is a policy associate with Women in Global Health and specialises in Universal Health Coverage. Together with colleagues from Women in Global Health and the Alliance for Gender Equality and UHC, she has advocated for gender equality in the health workforce and the inclusion of essential sexual and reproductive health services in UHC. Caitlin has a broad range of experience in global health, having worked on access to medicines with Médecins Sans Frontières, antimicrobial resistance with Public Health England, and palliative care policy with Chatham House. She is currently pursuing a medical degree from the University of Cambridge, where she also teaches pharmacology.

DR. SMITHA MUNDASAD
News Reporter
BBC
         
 
DR. SMITHA MUNDASAD
News Reporter
BBC
         
 

I am a reporter at the BBC, covering health, science and general news. My work has appeared on BBC national and world TV, Radio 4, BBC World Service and the BBC news website.

Previously, I worked as a children’s doctor in UK and abroad, including South Africa and India. 

In the last few years I have gained a journalism award from the Society for Neuroscience, a Medical Research Council prize, been sent to Turkey’s Nanotechnology Centre through a European Union science and society initiative, to Uganda through a fellowship from the Association of British Science Writers and have been awarded a Wellcome Trust mentorship for emerging talent.

Most recently I was part of the BBC team given the George Foster Peabody award and OJA Knight Foundation award for our coverage of the Ebola outbreak in West Africa.

DR. MANUEL GARCÍA-HERRANZ
Chief Scientist
UNICEF
         
 
DR. MANUEL GARCÍA-HERRANZ
Chief Scientist
UNICEF
         
 

Dr. Manuel García-Herranz is Chief Scientist at UNICEF’s Office of Innovation and Information and Communications Technology Division joint initiative on Big Data and Artificial Intelligence. He has been working with UNICEF for more than 6 years to bridge the gap between Data Science and the needs of the most vulnerable children. At UNICEF, he co-created the MagicBox program to build research and partnerships that can transform Big Data and Artificial Intelligence into equitable tools to better respond to epidemics or natural disasters and deliver results to the most vulnerable populations. Through the Science team, UNICEF Innovation has also been focusing on the future of digital vulnerabilities, working to identify and curve emerging computational inequalities such as bias in new sources of data and unfairness in algorithms. Manuel holds a PhD in computer science from the Universidad Autonoma de Madrid.

JOÃO ARTHUR REIS
Director - Science, Technology and Innovation Coordination
São Paulo State Government
         
 
JOÃO ARTHUR REIS
Director - Science, Technology and Innovation Coordination
São Paulo State Government
         
 

João works in the design and implementation of ST&I policy in the State of São Paulo and has previously worked with innovative entrepreneurship and international cooperation at the Maranhão Foundation for Research, Science and Technology Development – FAPEMA, through Vetor Brasil’s Public Sector Trainee Program, which develop young professionals in their careers in local and state governments in Brazil. João holds a Bachelor’s degree in International Relations – Federal University of Rio Grande do Sul and a M.A. in International Political Economy – Federal University of Rio de Janeiro.

CONNIE LOW
Co-Founder and Managing Partner
Impact Hub Basel
         
 
CONNIE LOW
Co-Founder and Managing Partner
Impact Hub Basel
         
 

Connie is Co-Founder and Managing Partner at Impact Hub Basel, part of a global Impact Hub Network building communities for impact, especially around social entrepreneurs contributing to the UN Sustainable Development Goals. Her work experience and passion to date revolved around Human Rights and Sustainability topics, particularly in large corporate supply chains and she has a large network engaged in sustainability topics globally. Impact Hub Basel participated in a nationwide consortium, with all the other Impact Hubs in Switzerland as well as 20+ other organizations, to co-organize VersusVirus within 2 weeks of the COVID-19 outbreak in Switzerland. They mobilized 5000+ citizens to work on solutions to tackle the COVID-19 pandemic in the Swiss context in an online hackathon from 3-6 April 2020

BEAT STEFFEN
Founder, Chairman & CEO
confinis
         
 
BEAT STEFFEN
Founder, Chairman & CEO
confinis
         
 

Beat U. Steffen, Founder, Chairman & CEO of confinis ag, (Switzerland and USA) holds a MSc in electrical engineering an executive MBA and has 25+ years of experience in medical device and combination product development/manufacturing/quality management/regulatory affairs. He worked for Disetronic and Ypsomed and was responsible for a number of development projects from the first idea to successful registration and commercialization as well as infrastructure projects.

He founded confinis ag (www.confinis.com) in 2005. Besides providing professional services and advice to clients in the medical device, pharmaceutical and biotech field (with particular expertise and experience in combination products), he works as a freelance auditor with a focus on EN ISO 13485, Council Directive 93/42/EEC, MDSAP (Medical Device Single Audit Program) and MDR EU 2017/745 (designation pending) for SQS and DQS.

In addition to confinis, he co-founded Medical Human Factors AG (https://med-hf.ch/) in 2016, a company specialized in evaluating the use-related safety, effectiveness and usability of medical products and confinis CPM (www.confinis-cpm.com/) in 2018, a virtual workplace that provides senior-level clinical project staff and functional service professionals to gather clinical data.

LAURA MCGORMAN
Policy Lead, Data for Good
Facebook
         
 
LAURA MCGORMAN
Policy Lead, Data for Good
Facebook
         
 
CAROLINE NOUBLANCHE
CEO
Apricity
         
 
CAROLINE NOUBLANCHE
CEO
Apricity
         
 

Caroline Noublanche is the founder and CEO of UK virtual fertility clinic, Apricity, and an experienced entrepreneur.

At age 27, Caroline co-founded mobile applications firm Prylos. She sold it to Swedish telecoms giant Doro AB in 2011, where she became vice president. More recently, she joined the AXA-backed incubator Kamet Ventures as an ‘entrepreneur in residence’ to help them build and launch disruptive startups in the health tech space.

Caroline recognised that IVF had experienced very little digital transformation in the past 40 years and was an area in need of disruption – this led her to found Apricity, the world’s first virtual fertility clinic, in 2018. Apricity has reimagined the fertility journey by combining technology and artificial intelligence with personalised care and medical expertise. Its digital solution is designed to improve the fertility experience and maximise chances of conception. It achieves this by providing access to world-class fertility advisors and a fully-customised treatment journey for patients, all easily navigated through a mobile app.

HASSAN CHAUDHURY
Digital Health Specialist
UK’s Department for International Trade
         
 
HASSAN CHAUDHURY
Digital Health Specialist
UK’s Department for International Trade
         
 

Hassan leads on Digital Health at Healthcare UK, Department for International Trade (DIT) supporting the best British HealthTech firms to export and the most innovative global firms to invest in the UK. He was a founder and CIO of Health iQ, an award-winning health analytics firm, holds an Honorary Research post at Imperial College London and is a Committee Member of the PM Society. He is part of the TECH4CV19 collective and contributes to both the World Healthcare Journal and PharmaField. The Financial Times named him in the top 100 most influential BAME leaders in UK tech in 2019.

NEIL SEBIRE
Chief Research Information Officer
Great Ormond Street Hospital
         
 
NEIL SEBIRE
Chief Research Information Officer
Great Ormond Street Hospital
         
 
RICHARD JONES
President & Chief Strategy Officer
C2-Ai
         
 
RICHARD JONES
President & Chief Strategy Officer
C2-Ai
         
 
GAVIN MATTHEWS
UK Business Development Director
SkinVision
         
 
GAVIN MATTHEWS
UK Business Development Director
SkinVision
         
 
OSKAR KIWIC
President and CEO
CardioCube
         
 
OSKAR KIWIC
President and CEO
CardioCube
         
 
DR. SUJOY KAR
Chief Medical Information Officer & Vice President
Apollo Hospitals
         
 
DR. SUJOY KAR
Chief Medical Information Officer & Vice President
Apollo Hospitals
         
 

Dr Sujoy Kar is the Chief Medical Information Officer & Vice President at Apollo Hospitals. Previously, he was the Director Medical Services at Apollo Gleneagles Hospitals Kolkata. He obtained his post graduate MD in Clinical Microbiology & Infectious Diseases and is an alumnus of MIT Sloan School of Management. He is a Certified Six Sigma Master Black Belt (Indian Statistical Institute) and member of professional organisations like ACHE, VRARA (Member – Healthcare Sub Committee), CHIME, Harvard Square (LE), ICMR – CIBioD (Member Task Force) and World Economic Forum – Chatbot & AI in Healthcare.

Dr Sujoy is currently associated with IIT Kharagpur & IIM Calcutta as Adjunct Faculty for Healthcare Analytics and Management. He has led teams in multiple award winning Patient Safety & Process Improvement projects. His current and ongoing research interests are in adoption of Artificial Intelligence & Blockchain Technology in Healthcare, Time Driven Activity Based Costing, Living Labs, Digital Health Platforms and Design Thinking in Healthcare.

SUELLEN CARVALHO
Project Leader
Grupo Tellus
         
 
SUELLEN CARVALHO
Project Leader
Grupo Tellus
         
 

Suellen has 12 year of experience in project management and strategic planning in the private sector. She currently leads social innovation projects at Grupo Tellus, where she has been collaborating with the State of São Paulo on the design, implementation and development of a business model for strategies that connect government problems with innovative solutions. Suellen holds a bachelor’s degree in Public Administration from the São Paulo State University (UNESP), a MBA in Project Management from the Fundação Getulio Vargas (FGV) and a Post-graduation in social projects management from the Amani Institute Nairobi – Kenya

DR. ALLISON GARDNER
Lecturer in Data Science, Programme Director for the Integrated Degree Apprenticeship in Data Science
Keele University
         
 
DR. ALLISON GARDNER
Lecturer in Data Science, Programme Director for the Integrated Degree Apprenticeship in Data Science
Keele University
         
 

Allison lectures at Keele University in Bioinformatics and Data Science and is the Programme Director for the Data Science Degree Apprenticeship. She is a co-founder of Women Leading in AI. Her research is primarily focused on algorithmic bias; gender and computing; AI Ethics and Governance of AI. She works on the IEEE P7000 Global Initiative on the Ethics of Autonomous and Intelligent Systems and the ISO standard on Artificial Intelligence. She speaks internationally on AI Ethics, the need for diversity in tech and the potential regulation and governance of AI. Allison acts as a consultant for a variety of companies on the ethical design of autonomous and intelligent systems and development of algorithmic impact assessments. She is also a district councillor and an alumnus of the first cohort of the Jo Cox Women in Leadership Programme.

ANDREAS CLEVE
Co-Founder and CEO
Corti
         
 
ANDREAS CLEVE
Co-Founder and CEO
Corti
         
 

Andreas Cleve is Corti’s co-founder and CEO. After spending nearly a decade working as a multi-entrepreneur in AI, Andreas founded Corti. Corti uses advanced voice- and pattern recognition technology to assist and augment medical professionals in predicting medical cases in real-time and provides them with intelligent decision support. It allows them to arrive at a conclusion faster and
to provide a better-informed treatment.

Andreas has always been incredibly passionate about the possibilities that AI can provide to the healthcare sector and how we can leverage advanced technology in our most vital industry. While serving as CEO of Corti, he founded Nordic.AI and now sits as chairman of the board. Nordic.AI was created as an anchor for the Nordic machine learning and AI community, it hosts early events and meetups, bringing all the great Scandinavian minds together. Andreas has landed coverage
in print and broadcast outlets all

DANIELLE RALIC
Founder and CEO
Ancora.ai
         
 
DANIELLE RALIC
Founder and CEO
Ancora.ai
         
 

Danielle Ralic, founder and CEO of Ancora.ai, has more than 10 years of experience in healthcare analytics. She worked previously at Deloitte and ZS Associates, implementing business intelligence solutions for healthcare clients in North America, Europe, and Asia. Danielle graduated from Boston College with a degree in information systems with a focus on healthcare information technology. She has worked with 10+ Pharma companies to deliver business technology projects worth more than 10M dollars, including AI and machine learning solutions. 

CAITLIN KRAFT-BUCHMAN
CEO/Founder
Women at the Table
         
 
CAITLIN KRAFT-BUCHMAN
CEO/Founder
Women at the Table
         
 

Caitlin Kraft-Buchman is CEO/Founder of Women at the Table, a growing global CSO based in Geneva – and the first organization to focus on systems change by helping feminists gain influence in sectors that have key structural impact: economy, democracy and governance, technology, and sustainability.

Women at the Table exposes systematic exclusion of women in defining the rules – and pinpoints strategic changes to laws, regulations and norms to achieve gender equality and strengthen democracy.  A systems change entrepreneur Caitlin co-founded the global  <A+> Alliance for Inclusive Algorithms to correct real life bias and barriers that prevent women from achieving their full participation and rights in the present, and in the future, we invent. In 2020, <A+> was recognized as one of Fast Company’s 2020 World Changing Ideas: AI & Data, and became a leader of UN Women’s Generation Equality Action Coalition on Technology and Innovation for Gender Equality.

Caitlin is one of three co-founders of the International Gender Champions (IGC) a leadership network of female & male decision-makers breaking down gender barriers for system change. Founded in 2015, IGC counts the UN Secretary General, heads of the WHO, ILO, WTO, WIPO, ITU, ISO, amongst 250+ Champion Heads of Organizations, Ambassadors, and Civil Society, now including Hubs in Geneva, New York, Vienna, Nairobi, The Hague and Paris. The IGC Trade Impact Group is responsible for the ‘Buenos Aires Declaration on Trade and Women’s Economic Empowerment’ joined by 120+ Member States, and the ‘Gender Responsive-Standards Declaration’ signed by 50+  standards bodies. 

 

GRATIANA FU
Associate Data Scientist
Center for Digital Acceleration - DAI Global Health
         
 
GRATIANA FU
Associate Data Scientist
Center for Digital Acceleration - DAI Global Health
         
 

Gratiana Fu is a Data Scientist with DAI’s Center for Digital Acceleration in Washington, DC. She supports DAI’s portfolio of projects to collect, use, & analyze data; integrate data and digital tools into decision-making processes; and apply data science techniques ethically and sustainably. She also volunteers with Women in Global Health and the Racial Equity Index Working Group, a group dedicated to exploring the lack and need for a racial equity index within international development. Prior to joining DAI, she worked as a Global Health Corps Fellow in Rwanda, where she designed and developed a national heart disease registry, conducted digital health trainings, and managed a mobile health platform for improving post-surgical care. She holds a Master’s degree in health informatics and BS in Sociology, both from the University of Michigan. In her free time, she enjoys running.

RACHEL SIBANDE
Program Director - Data for Development
Digital Impact Alliance, at the United Nations Foundation
         
 
RACHEL SIBANDE
Program Director - Data for Development
Digital Impact Alliance, at the United Nations Foundation
         
 

Rachel Sibande is Program Director, Data for Development at the Digital Impact Alliance, a unit within the United Nations Foundation. She leads sector wide Big data for development models across countries in Africa, supporting Governments to leverage the power of Big data for decision making. Recently, Rachel has led the development of risk and epidemiology models for COVID19 that integrate mobility metrics generated from Mobile Network Operator data and Geospatial data. The models would help Governments understand where to anticipate COVID19 hotspots, stock outs and health facility burden prior. These Big Data models have been developed for Malawi and 14 other West African Countries under the West African Health Organisation regional block. Rachel is  also leading on the integration of geospatial data, mobile network operator data and immunisation data to enhance immunisation outcomes in Tanzania.She has also led the development of resources used by practitioners in the big  data for development space to get started deploying similar initiatives. Her work cuts across a new space in the Big Data and AI space as it seeks to  integrate traditional digital health data and non traditional data sets such as mobile network operator data  largely to help understand mobility patterns of people and how they impact health outcomes.

PETER GRINBERGS
Co-Founder and Chief Medical Officer
EQL
         
 
PETER GRINBERGS
Co-Founder and Chief Medical Officer
EQL
         
 

Meet our previous AI healthcare heroes

DR. TOBY COSGROVE

Executive Advisor and Former President & CEO
Google & Cleveland Clinic

DR. TOBY COSGROVE

Executive Advisor and Former President & CEO
Google & Cleveland Clinic

Toby Cosgrove, MD, is former CEO and president of Cleveland Clinic. Serving from 2004 through 2017, he led the $8 billion organization to new heights of achievement and efficiency, seeing it ranked the #2 hospital in America (U.S. News). He currently serves as Executive Advisor, working with Cleveland Clinic leadership on strategies for national and international growth.

 

Dr. Cosgrove graduated from Williams College and the University of Virginia School of Medicine. He trained at Massachusetts General Hospital and Brook General Hospital in London. In 1967, he was a surgeon in the U.S. Air Force, earning a Bronze Star.

 

Dr. Cosgrove joined Cleveland Clinic in 1975, and chaired the Department of Thoracic and Cardiovascular surgery from 1989 to 2004. He performed over 22,000 operations and earned an international reputation in valve repair He holds 30 patents for medical innovations. As CEO from 2004 to 2017, he reorganized services, improved outcomes and patient experience, and strengthened the organization’s finances.

 

He is a member of the National Academy of Medicine, and a Fellow of the National Academy of Inventors. In 2016, he was a Fortune Businessperson of the Year (No. 14). Three successive presidents of the United States have consulted him on healthcare issues.

DR. PETER LEE

Corporate Vice President, Healthcare
Microsoft

DR. PETER LEE

Corporate Vice President, Healthcare
Microsoft

Dr. Peter Lee is Corporate Vice President, Microsoft Healthcare. He leads an organization that works on technologies for better and more efficient healthcare, with a special focus on artificial intelligence and cloud computing. Dr. Lee has extensive experience in managing the process of going from basic research to commercial impact. Past illustrative examples include the deep neural networks for simultaneous language translation in Skype, next-generation IoT technologies, and innovative silicon and post-silicon computer architectures for Microsoft’s cloud. He also has a history of advancing more “out of the box” technical efforts, such as experimental under-sea datacenters, augmented-reality experiences for HoloLens and VR devices, digital storage in DNA, and social chatbots such as XiaoIce and Tay. Previously, as an Office Director at DARPA, he led efforts that created operational capabilities in advanced machine learning, crowdsourcing, and big-data analytics, such as the DARPA Network Challenge and Nexus 7. He was formerly the Head of Carnegie Mellon University’s computer science department. As a thought leader, he has spoken and written widely on technology trends and policies, spanning the fields of computing technology, healthcare, and innovation ecosystem. He is a member of the Boards of Directors of the Allen Institute for Artificial Intelligence and the Kaiser Permanente School of Medicine. He served on President’s Commission on Enhancing National Cybersecurity. He has led studies for the National Academies on the impact of federal research investments on economic growth and testified before the US House Science and Technology Committee and the US Senate Commerce Committee.

BERNARDO MARIANO JUNIOR

Director, Digital Health and Chief Information Officer
World Health Organization

BERNARDO MARIANO JUNIOR

Director, Digital Health and Chief Information Officer
World Health Organization

Bernardo Mariano Junior is the Director of the Digital Health Department and the Chief Information Officer of WHO. He is responsible for setting and maintaining the vision and direction of WHO’s strategy of health in the digital age. As CIO, he ensures that the digital transformation of WHO enhances the organization’s collective performance and efficiency to deliver the ‘Health for all’ global development agenda.

Prior to joining WHO, Mr. Mariano held senior managerial positions in the International Organization for Migration as Senior Regional Adviser for Sub-Saharan Africa in the office of the Director-General, Chief Information Officer/Director, Information & Communications Technology, and Regional Director for East and Southern Africa.

PROF GARY MARCUS

Professor of Psychology and Neural Science
New York University

PROF GARY MARCUS

Professor of Psychology and Neural Science
New York University

Gary Marcus, scientist, bestselling author, and entrepreneur, was CEO and Founder of the machine-learning startup Geometric Intelligence, recently acquired by Uber, and is known for his provocative and bold claims in artificial intelligence, neuroscience, and cognitive science. Trained by Steven Pinker, he received his PhD at MIT at age 23. His professional research, published in leading journals such as Science, Nature, Cognition, and Artificial Intelligence, has focused on the foundations of cognition in humans, animals and machines, spanning fields from developmental psychology to neuroscience to genetics to artificial intelligence. A special interest has been on the challenge of endowing machines with common sense.

 

He is also well-known for his writing for the general public, including frequent essays and op-eds for The New Yorker and The New York Times. His books include The Algebraic Mind, The Birth of the Mind, Kluge: The Haphazard Evolution of the Human Mind, The New York Times Bestseller, Guitar Zero and The Future of the Brain: Essays By The World’s Leading Neuroscientists.

 

In a 2012 essay for The New Yorker, he was perhaps the first person to publicly criticize deep learning, drawing on arguments he developed in his 2001 technical book The Algebraic Mind. More recently, in a 2018 arXiv article, Deep Learning: A Critical Appraisal, he asked whether deep learning might be “approaching a wall.” The challenges he laid out there were covered everywhere from The
New York Times to Wired to The Financial Times and Wall Street Journal.

 

In another provocative 2012 essay, Moral Machines, Marcus was the first to adapt “trolley problems” to driverless cars, anticipating much recent research on the ethics of AI. His next book, REBOOT: Getting to AI We Can Trust, to be published by Pantheon in Fall 2019, co-authored with Ernie Davis, calls for a fundamental rethinking of current approaches to artificial intelligence.

VANESSA CANDEIAS

Head, Global Health and Healthcare and Member of the Executive Committee
World Economic Forum

VANESSA CANDEIAS

Head, Global Health and Healthcare and Member of the Executive Committee
World Economic Forum

Trained as a nutritionist, Faculty of Nutrition and Food Sciences, Porto University; Master’s in Public Health, London School of Hygiene and Tropical Medicine. Formerly: worked at national level on developing and implementing health promotion policies with the Ministry of Health in Portugal and the Institute of Preventive Medicine of the University of Lisbon; worked with the World Health Organization Headquarters on global guidelines and policy development for noncommunicable diseases.

 

Currently, Head of System Initiative on Shaping the Future of Health and Healthcare and Member of the Executive Committee, World Economic Forum. The System Initiative on Shaping the Future of Health and Healthcare provides a dynamic platform for leading businesses, governments, civil society organizations and world-class experts to shape the global health agenda; co-design and accelerate the implementation of collaborative approaches that transform the health ecosystem – across prevention, diagnosis, treatment, cure and maintenance of health; and ultimately enables populations to live healthier lives and have access to the care they need when they need it.

KIMBERLY POWELL

Vice President Healthcare
NVIDIA

KIMBERLY POWELL

Vice President Healthcare
NVIDIA

Kimberly Powell is vice president of healthcare at NVIDIA, where she leads the company’s efforts to build healthcare computing platforms that address grand challenges like early detection, diagnoses and personalized treatment.

Partnering with healthcare researchers, startups and industry leaders, her mission is to accelerate the adoption of advanced computing technologies like GPU computing and artificial intelligence.

Powell joined NVIDIA in 2008 as the global business development manager for healthcare. She also served as senior director of AI business development. Prior to joining NVIDIA, she was a product manager for diagnostic imaging at Planar Systems and a hardware engineer at DOME Imaging Systems doing FPGA design.

Powell has a Bachelor of Science from Northeastern University in electrical engineering with a concentration in computer engineering.

BAKUL PATEL
Associate Centre Director for Digital Health
FDA
BAKUL PATEL
Associate Centre Director for Digital Health
FDA

Bakul Patel is Associate Director for Digital Health, at the Center for Devices and Radiological Health (CDRH), at the Food and Drug Administration (FDA).  Mr. Patel leads regulatory policy and scientific efforts at the Center in areas related to emerging and converging areas of medical devices, wireless and information technology. This includes responsibilities for mobile health, health information technology, cyber security, medical device interoperability, and medical device software. 
 

Mr. Patel is the FDA liaison between the Federal Communications Commission (FCC) and the Office of the National Coordinator (ONC). Since its inception in 2013, Bakul chairs the International Medical Device Regulators Forum (IMDRF) “software as a medical device” working group, a global harmonization effort.

Before joining FDA, Mr. Patel held key leadership positions working in the telecommunications industry, semiconductor capital equipment industry, wireless industry and information technology industry. His experience includes Lean Six Sigma, creating long and short-term strategy, influencing organizational change, modernizing government systems, and delivering high technology products and services in fastpaced, technology-intensive organizations.
 

Mr. Patel earned an MS in Electronic Systems Engineering from the University of Regina, Canada, and an MBA in International Business from The Johns Hopkins University.

MARK O’HERLIHY

Managing Director EMEA
IBM Watson Health

MARK O’HERLIHY

Managing Director EMEA
IBM Watson Health

Head of IBM Watson Health for Europe, Middle East & Africa. As the Managing Director, Mark holds full responsibility for the Sales & Go to Market strategy & team, for Watson Health software products and solutions to their customers. This includes the full portfolio of Life Sciences, Oncology, Genomics, Imaging, Government, Value-Based Care & Population Health Management solutions.

 

Mark has a clinical background and has worked in the NHS as well as many senior leadership positions in global, European and start-up healthcare companies throughout his career, with over 25 years of experience in the healthcare segment, Mark brings a wealth of experience and perspective and he is passionate about health and social care for everyone.

DR. ANN AERTS

Head
Novartis Foundation

DR. ANN AERTS

Head
Novartis Foundation

Ann Aerts has been Head of the Novartis Foundation since January 2013, an organization committed to having a transformational impact on the health of low-income populations. Ann holds a Degree in Medicine and a Masters in Public Health from the University of Leuven, Belgium, and a Degree in Tropical Medicine from the Institute of Tropical Medicine in Antwerp, Belgium. In 2014, Ann was nominated by PharmaVOICE as one of the 100 Most Inspiring People in the life science industry. Ann has authored numerous publications and is a member of the Broadband Commission for Sustainable Development, the Governing Council of the UN Technology Bank for Least Developed Countries and the International Advisory Board of the Commonwealth Centre for Digital Health.

PROF. WEIHONG HUANG

Mobile Health Ministry of Education – China Mobile Lab
Xiangya Hospital Central South University

PROF. WEIHONG HUANG

Mobile Health Ministry of Education – China Mobile Lab
Xiangya Hospital Central South University

Weihong Huang received the B.Eng. degree in automation and M.Eng. degree in pattern recognition and smart control from Southeast University China in 1995 and 1998 respectively and the Ph.D. degree in computer science from Nanjing University China in 2001. From 2001 to 2002, he was a Post-doctoral Research Fellow with the CNRS University Lyon 1 France. From 2002 to 2005, he was a lecturer with the Department of Computer Science, University of Hull, United Kingdom. From 2005 to 2014, he was a senior lecturer with School of Computer and Information Systems, Kingston University London, United Kingdom. Since 2016, he was appointed as a professor and the Depute Director of the Mobile Health Ministry of Education – China Mobile Joint Laboratory, Xiangya Hospital Central South University, China. His research interests include mobile health, artificial intelligence in healthcare, cognitive computing for healthcare, semantic multimedia computing and knowledge graph applications. Prof. Huang is a committee member of China Hospital Information Management Association, standing committee member of the Medical and Health Big Data Evaluation and Assurance board of the Chinese Health Information and Big Data Association, chairman of specialized committee of information management of Hunan Health Management Association.

ROLAND ROTT

Global General Manager of Women´s Health Ultrasound
GE Healthcare

ROLAND ROTT

Global General Manager of Women´s Health Ultrasound
GE Healthcare

Roland Rott is the global General Manager of Women´s Health Ultrasound at GE Healthcare, the market leader of Ultrasound for Obstetrics/Gynecology worldwide. The Voluson product line for Women´s Health has been pioneering Ultrasound and AI technology and is touching more than 250 million lives globally every year.


Roland leads the global product organization, consisting of clinical and product management, research & development, installed base customer service, quality management and is responsible for innovation and manufacturing sites in Austria, Germany and Korea.

 

Before joining GE in 2011, Roland was Managing Director EMEA and Executive board member of Exact Software – a midcap public company headquartered in the Netherlands – leading 4 R&D teams and subsidiaries in 20 countries spanning over Europe/Middle/East, Africa & Asia. In his early career, Roland had an entrepreneurial start, founded two software companies in Austria and successfully sold those to strategic investors.


Roland has a software engineering background, studied International business administration and took executive education courses on strategy and Innovation in Stanford University and the London Business school. He is based in Vienna, Austria and lives there with his wife, two teenage kids and a toddler
.

DR. RAMYA PALACHOLLA

Lead Scientist & Faculty
Partners HealthCare & Harvard Medical School

DR. RAMYA PALACHOLLA

Lead Scientist & Faculty
Partners HealthCare & Harvard Medical School

Ramya Palacholla is a Physician and one of the Lead Scientists at Partners Healthcare Pivot Labs. She is also a faculty member of the Harvard Medical School. Currently, Dr. Palacholla works with a multidisciplinary team that develops and executes digital health strategy and research projects in collaboration with top pharmaceutical, research and medical technology companies. She is passionate about her research focused on validation of innovative health technology solutions for improving patient lives. Dr. Palacholla has published her work in several health care journals and presented her research on innovative technologies on international platforms such as the World Economic Forum (also presented at the G8 Summit), served as a reviewer for health technology journals, and spoken at national conferences as a thought leader in the field of health care research and innovation. Her cutting edge research in this area is recognized for its high caliber, and she continues to advance this field to new frontiers. Dr. Palacholla’s idea on an “Innovative Tumor Response Forecasting Model in Breast Cancer Patients” was awarded the first position in the Harvard Ideation Challenge among hundreds of submissions received from across the country. Furthermore, the idea was also selected as one of the top six finalists for the Boston Scientific and Google Connected Patient Challenge, 2018, which is unquestionably a renowned platform that showcases healthcare innovations across the globe. She was also a co-author of one of the first books to be written on proven treatment methods for the management of Military Sexual Trauma and PTSD in war veterans. Following these successes, Dr. Palacholla’s research is well-known in the healthcare innovation space and has given her opportunities to present her research work at national healthcare conferences and summits.

DR. BORIS BOGDAN

Managing Director, Lead – Global Precision Oncology and Personalized Healthcare (PHC)
Accenture Life Sciences

DR. BORIS BOGDAN

Managing Director, Lead – Global Precision Oncology and Personalized Healthcare (PHC)
Accenture Life Sciences

DR. OLIVER MORGAN

Director of Health Emergency and Risk Assessment
World Health Organization

DR. OLIVER MORGAN

Director of Health Emergency and Risk Assessment
World Health Organization

Dr. Oliver Morgan is the Director of the Health Emergency Information and Risk Assessment Department in the WHO Health Emergencies Program. From 2007 through 2016, Dr. Morgan worked for the US Centers for Disease Control and Prevention during which time he held critical leadership positions in the Ebola response between November 2014 and February 2016 (CDC Atlanta Ebola Response Incident Manger and CDC Country Director in Sierra Leone).From March 2010 to October 2014, Dr. Morgan was the CDC Country Director in the Dominican Republic. Dr. Morgan was an Epidemic Intelligence Service Officer at CDC from 2007 to 2009 with the International Emerging Infections Program, during which time he conducted projects in Thailand, Bangladesh, Kenya, Uganda, and Guatemala. Before joining CDC, Dr. Morgan worked for the UK Health Protection Agency, leading epidemiological investigations of outbreaks (enteric, vaccine preventable, hospital acquired, zoonotic, respiratory, and sexually acquired infections), chemical and radiation exposure incidents, terrorist bombings in London, natural disasters, and humanitarian civil conflicts. Dr. Morgan has also worked as a consultant to WHO/PAHO in several countries. Dr. Morgan’s academic achievements include a doctorate in epidemiology from Imperial College London and extensive publication in peer reviewed journals and reference books.

DR. NATALIE BANNER

Understanding Patient Data Lead
Wellcome Trust

DR. NATALIE BANNER

Understanding Patient Data Lead
Wellcome Trust

Dr Natalie Banner is the Lead for Understanding Patient Data (UPD), an initiative hosted at the Wellcome Trust to support better conversations about how patient data is used for care and research. UPD works with patients, charities and health professionals to champion responsible uses of data, feeding into policy development, creating accessible resources and horizon scanning for emerging issues that may affect public confidence in the use of health data.

 

This includes exploring emerging data-driven technologies and how to create the right ethical and governance frameworks for these in healthcare and research. Natalie formerly led Wellcome’s policy work on GDPR and data protection, seeking to ensure UK legislation and regulation creates a supportive, trustworthy environment for health research using patient and health-related data. She was recently named in BioBeat’s “50 Movers and Shakers in BioBusiness” for 2018.

PROF. DR. EFFY VAYENA

Professor
Institute of Translational Medicine

PROF. DR. EFFY VAYENA

Professor
Institute of Translational Medicine

DR. ALAIN DAGHER

Neurologist and Professor
Montreal Neurological Institute, McGill University

DR. ALAIN DAGHER

Neurologist and Professor
Montreal Neurological Institute, McGill University

Dr. Dagher is an M.D./Ph.D. who studied Electrical Engineering and Medicine. He is a Neurologist and Professor at McGill University in Montreal (clinician and scientist). His research aims to understand brain reward systems and their role in neurological and psychiatric illness.

 

He uses brain imaging, notably functional magnetic resonance imaging (fMRI), to map brain activity in response to drugs or natural rewards like food and music. He is particularly interested in figuring out what in the brain makes individuals vulnerable to mental illness. He splits his professional life between clinical neurology and research and teaching. He sees people with Parkinson’s Disease in his clinic once a week. Dr. Dagher teaches medical students and Ph.D. students in neuroscience.

DR. STEPHANIE KUKU

Senior Consultant
Hardian Health
 

DR. STEPHANIE KUKU

Senior Consultant
Hardian Health
 

Stephanie is an NHS Clinical Entrepreneur and Senior Research Fellow at UCL and UCLH where she was awarded a Doctorate in Clinical Research in Oncology. Research Interests include Integrated Data Models for Cancer Monitoring, Survivorship and Longevity. A Clinician-Scientist with over 10 years experience, Stephanie has served on council on a National Cancer Society (BGCS) and is the Healthcare Ambassador of the global organisation Women in AI (WAI). She is a Scientific Advisor to WILD.AI and the Havas Lynx Faculty and on the Advisory Committee of the Social Impact Community, the Conduit, London.

ELENA BONFIGLIOLI
Managing Director Health and Life Sciences
Microsoft EMEA
ELENA BONFIGLIOLI
Managing Director Health and Life Sciences
Microsoft EMEA

Elena Bonfiglioli, Managing Director Health and Life Sciences, Microsoft EMEA
Elena Bonfiglioli leads the Health and Life Sciences Industry business for Microsoft in Europe, Middle East and Africa, and is part of the World Wide Commercial Business Team. She is responsible for driving strategy and business development, partnerships, and positioning for the region across public health, social services, providers, and pharma. Elena is an advocate for the transformation of healthcare systems with Cloud and AI.

DR. INDRA JOSHI

Director of AI
NHSX

DR. INDRA JOSHI

Director of AI
NHSX

Dr Indra Joshi is the acting Director of AI for NHSX, leading on the creation of the NHS AI Lab. Her other responsibilities include overseeing digital health initiatives within the NHS with a focus on data, digital health standards and evidence.

Indra has a unique portfolio with experience stretching across policy, digital health, national project strategy and implementation; whilst remaining true to her professional training as an emergency medic.

She is a Founding Member of One HealthTech – a network which campaigns for the need and importance of better inclusion of all backgrounds, skill sets and disciplines in health technology. Alongside she is a Vice-Chair for the British Computer Society (Health), an international speaker and consultant on digital health, an expedition medic, and most importantly a mum to two wonderful little munchkins.

PROF LUCIANO FLORIDI

Professor of Philosophy and Ethics of Information and Director
The University of Oxford and Digital Ethics Lab

PROF LUCIANO FLORIDI

Professor of Philosophy and Ethics of Information and Director
The University of Oxford and Digital Ethics Lab

Luciano Floridi is the OII’s Professor of Philosophy and Ethics of Information at the University of Oxford, where he is also the Director of the Digital Ethics Lab of the Oxford Internet Institute. Still in Oxford, he is a Distinguished Research Fellow of the Uehiro Centre for Practical Ethics of the Faculty of Philosophy, and Research Associate and Fellow in Information Policy of the Department of Computer Science. Outside Oxford, he is Faculty Fellow of the Alan Turing Institute (the national institute for data science) and Chair of its Data Ethics Group; and Adjunct Professor (“Distinguished Scholar in Residence”) of the Department of Economics, American University, Washington D.C.

 

His research concerns primarily Information and Computer Ethics (aka Digital Ethics), the Philosophy of Information, and the Philosophy of Technology. Other research interests include Epistemology, Philosophy of Logic, and the History and Philosophy of Scepticism. He has published over 150 papers in these areas, in many anthologies and peer-reviewed journals.

DR. LOUBNA BOUARFA

CEO and Founder & High Level Expert on AI
OKRA Technologies & European Commission

DR. LOUBNA BOUARFA

CEO and Founder & High Level Expert on AI
OKRA Technologies & European Commission

Dr Loubna Bouarfa is a machine learning scientist turned entrepreneur.

She is the founder and CEO of OKRA Technologies – an artificial intelligence data analytics company for healthcare. OKRA allows healthcare professionals to combine all their data in one place and generate evidence-based insights in real time, to save and improve human lives. Loubna is currently a member of the European Union High-Level Expert Group on Artificial Intelligence, where she is particularly focused on healthcare and achieving competitive business impact with AI. She was named an MIT Technology Review Top Innovator Under 35, a Forbes 50 Top Women In Tech, and recently won the prize for Best Female-Led Startup at the StartUp Europe Awards. On a personal level, she is a strong advocate for diversity, women and challenging the status quo.

For more information on OKRA, visit ​okra.ai​ and find us on ​LinkedIn​ and ​Twitter​. 

JESS MORLEY

Tech Lead for AI
NHSX

JESS MORLEY

Tech Lead for AI
NHSX

Jess (@jessRmorley) is the tech lead for AI in NHSX responsible for developing policies such as the Code of Conduct for data-driven health and care technology, and assessing the readiness of the regulatory framework to cope with emerging technologies. She is also a researcher in the Oxford Internet Institute’s Digital Ethics Lab,  and focuses on ‘Governing the Digital Health Ecosystem.’ In both capacities, she is passionate about ensuring ‘society’ is kept-in-the-loop and all people are given a voice in how, when and why data-driven tech is integrated into the NHS and broader health and care system. 

DR. ASIF JAN

Group Director of Analytics in Personalised Healthcare
Roche

DR. ASIF JAN

Group Director of Analytics in Personalised Healthcare
Roche

Asif Jan leads a multidisciplinary team of scientists specializing in computer science, neuroscience, and statistics. The team implements a variety of statistical and machine learning methods on real-world datasets (e.g. electronic medical records, health insurance claims, disease registries) to fulfill evidence and data analysis needs of the Neuroscience disease area at Roche. Previously, he was Head of Data Science at Roche Diagnostics leading a team of quantitative scientists supporting in vitro diagnostics and clinical decision support product development, where he defined data strategy enabling the use of real-world data. Earlier he has had a number of roles overseeing technology strategy development, enterprise and solution architecture, and program management at Roche and in other research organizations. Asif has vast experience of building and leading data science teams in pharma and diagnostics companies, and industrial research institutes, tackling complex scientific and business problems. He strongly believes that the intersection of strategy, technology and data science is needed to fight diseases, thereby enabling better care for everyone.

Asif holds a PhD in Neuroscience (informatics) from the Swiss Federal Institutes of Technology Lausanne (EPFL), Switzerland, and an MPhil in Computer Science from the University of the West of England, Bristol, UK.

CHARLES ALESSI

Chief Clinical Officer
HIMSS International

CHARLES ALESSI

Chief Clinical Officer
HIMSS International

Charles Alessi is the Chief Clinical Officer for HIMSS International. HIMSS is a global voice, advisor and thought leader of health transformation through health information and technology with a unique breadth and depth of expertise and capabilities to improve the quality, safety, and efficiency of health, healthcare and care outcomes.

As Chief Clinical Officer for HIMSS International, Alessi leads relationship-building efforts among HIMSS’s various international clinician-focused communities; furthering HIMSS’s position as a thought leader in the health industry and supporting both the vision and understanding of information and technology’s roles in the advancement of health and care.

Before joining HIMSS in 2018, Alessi has acted in numerous external positions for governments and executive agencies on a national and international level. Alessi brings more than 25 years of experience in global healthcare policy and clinical practice to HIMSS. Most recently, he chaired the National Association of Primary Care (NAPC), has served as an adjunct research professor for Clinical Neurosciences at the Schulich School of Medicine for University of Western Ontario Canada, and as executive director of the Global International Care Delivery Alliance.

Alessi is also the senior advisor for Public Health England, leading national policy implementation, productive healthy aging and is currently contributing to the global World Health Organization guidelines for dementia risk reduction. Alessi has also contributed his expertise to multiple international publications such as the British Journal of General Practice, addressing topics such as health and social care contract and health policy. He has lectured and led keynote addresses for healthcare engagements taking place on every continent (except Antarctica).

AMANDEEP GILL

Project Lead, I-DAIR and Former Executive Director, UNSG High Level Panel on Digital Corporation
United Nations

AMANDEEP GILL

Project Lead, I-DAIR and Former Executive Director, UNSG High Level Panel on Digital Corporation
United Nations

Amandeep Singh Gill joined the Indian Foreign Service in 1992.

He has served abroad at the Indian Mission to the UN and the Conference on Disarmament in Geneva (1994-1996, 2010-2013), the Indian Embassy in Tehran (2001-2004) and the High Commission of India in Colombo (2004-2006). At headquarters in New Delhi, he has served thrice in the Disarmament and International Security Affairs Division (1998-2001, 2006-2010 and 2013-2016) as well as in the United Nations Division (1996-1998). He served as the Head of the Disarmament and International Security Division in the Ministry of External Affairs from 2013 to 2016. He has also served as an expert on the UN Secretary General’s panels of experts on the Fissile Material Cut-off Treaty (FMCT), Small Arms and Light Weapons and on Missiles. He participated in the UN Disarmament Fellowship programme in 1999.

He is the current Chair of the Group of the Group of Governmental Experts (GGE) of the Convention on Certain Conventional Weapons (CCW) on Lethal Autonomous Weapons Systems (LAWS). He is also President-designate of the 2017 Meeting of States Parties to the Biological and Toxin Weapons Convention (BTWC).
Amandeep Singh Gill has a B. Tech in engineering from Punjab University, Chandigarh and an Advanced Diploma in French History and Language from Geneva University. His PhD from the Department of War Studies at King’s College, London is on Nuclear Learning in Multilateral Forums. During 2008-2009, he was a visiting scholar at Stanford University’s Center for International Security and Cooperation (CISAC) on an Asia Foundation regional security studies fellowship. As a scholar he has contributed to the Bulletin of Atomic Scientists, the Lowy Institute, the East West Institute, the Center for a New American Security and the Indian Economic and Social History Review.

Amandeep Singh Gill was born in 1968 in Chandigarh. He is married to Ashma Singh and has a daughter (Bani) and a son (Ujjay). His personal interests include creative writing, yoga and sustainable agriculture. His first book of poems in English was published by Wisdom Tree in 2016.

NAOMI LEE

Senior Executive Editor – Research
The Lancet

NAOMI LEE

Senior Executive Editor – Research
The Lancet

Naomi Lee is a Senior Executive Editor at the leading medical journal The Lancet. She has responsibility for research, leading the development and implementation of the research strategy for The Lancet, and advising on the research content of the other journals in The Lancet family of journals. Naomi handles peer review and commissioning across a broad range of subjects including her specialist areas of surgery, digital medicine/AI, and medical technology. She is also a vice chair for the ITU/WHO Focus Group on Artificial Intelligence for Health.

Naomi joined The Lancet in 2014 and was previously the Executive Editor (Digital) where alongside editorial work she led the internal and external digital transformation of The Lancet group. Previously she studied medicine at Cambridge University and King’s College London, before training in surgery, specialising in urology and working for almost 10 years in the United Kingdom. She has completed fellowships in Argentina, and Mexico. She has also studied data science at University College London.

DR. LIAM CAFFERY

Telehealth Technology Director
University of Queensland

DR. LIAM CAFFERY

Telehealth Technology Director
University of Queensland

Liam has a PhD in Medicine. His research is centred on pragmatic trials of telehealth services. Liam has a special interest in the use of telehealth for Indigenous health and rural health care delivery. He is involved in telehealth service development, delivery and evaluation across a broad range of telehealth services, namely, Princess Alexandra Hospital Telehealth Centre, Child and Youth Forensic Outreach ServiceseGROW,  Health-e-RegionsDREAMT and the Diamond Jubilee Fund’s Telehealth network. Liam uses implementation research principles to understand why telehealth services work well in some scenarios and not others. He evaluates the effectiveness of telehealth from multi-disciplinary perspectives including clinical effectiveness, patient perspectives, economic aspects, organisational aspects, and socio-cultural, ethical and legal aspects.

 

Liam also has an active research agenda in health informatics, in particular, in imaging informatics. Liam chairs the metadata group for the International Skin Imaging Collaboration: Melanoma Project. This project is an academia and industry partnership designed to facilitate the application of digital skin imaging to help reduce melanoma mortality – his work promotes the adoption of standards for digital imaging of the skin. Liam has previously been a member of the Standards Australia IT-014 Health Informatics technical committees for telehealth and messaging and communication.

 

Liam is executive member of the Australasian Telehealth Society and the International Teledermatology Society. He is a member of the Metro South Health Telehealth Advisory Group and a member of the Queensland Health mHealth Apps Working Group. Liam is an editorial advisor for the the Health Information Management Journal.

 

Liam has 25 years industry experience as a health informatician. His immediate past role was the Manager of Medical Imaging Informatics at the Royal Brisbane and Women’s Hospital. Previously, Liam had over a decade’s clinical experience as a diagnostic radiographer.

ALESSANDRO RAIMONDO

Medical Applications Officer - Knowledge Transfer Group
CERN

ALESSANDRO RAIMONDO

Medical Applications Officer - Knowledge Transfer Group
CERN

Alessandro joined CERN’s Knowledge Transfer Group in September 2018 as Knowledge Transfer Officer for Medical Applications, with the asset of a deep knowledge of the Organisation both in the technology and administrative domains.

Alessandro first came at CERN in 1995 working as experimental particle physicist; then he became fellow in 1999 and staff in 2001, being responsible for a variety of activities in the domains of data acquisition, control and measurement systems for the accelerator and technology sector.

In 2012, Alessandro decided to move to the administration sector to work mainly for the CERN Pension Fund, covering different roles including vice-chair of the Governing Board and chair of the Investments Committee.

Alessandro holds a PhD in Physics (1997) from University of Turin and an MBA (2016) from Guglielmo Marconi University of Rome. He also holds the qualifications of Professional Physics (2019) and Certified Internal Auditor (2017) with a Master on Fraud Investigation (2019).

STEFAN GERMANN

CEO
Fondation Botnar

STEFAN GERMANN

CEO
Fondation Botnar

Stefan Germann is CEO of Fondation Botnar, a large foundation in Basel (Switzerland) focused on child health, nutrition and education. He was formerly Executive Director of onegoal.org (an innovative collaborative child nutrition and healthy lifestyle campaign) and Senior Director of World Vision International’s Sustainable Health Partnership, Innovation and Accountability unit based in Kuala Lumpur, Malaysia.

 

He has worked for more than 15 years in Africa in different leadership roles with various agencies related to child health development, relief and advocacy work. His work included managing a large rural hospital in Zimbabwe. He has held a number of board and advisory board memberships (Partnership for Maternal, Newborn and Child Health, UBS Optimus Foundation, REPSSI in Africa) and currently sits on the Advisory Board of the Global Health Program, The Graduate Institute – Geneva focusing on the role of NGOs in global health diplomacy.

 

He holds a micro-engineering BSc degree, an MSc degree (Economics) in Social Policy & NGO Management and, in 2005, completed a doctoral degree in Development focused on child wellbeing in an urban African context. In 2015, Stefan graduated from the Executive Masters program in Tri Sector Collaboration at Singapore Management University.

JAQUIE FINN

Global Head of Digital Health
Cambridge Consultants

JAQUIE FINN

Global Head of Digital Health
Cambridge Consultants

Jaquie is Head of Digital Health at Cambridge Consultants and leads the initiative to provide strategic guidance and technical solutions for clients transitioning their business model to include a digital element. These digital elements include device connectivity, AI, security, launch strategies, behavioural science and digital service design.

 

Jaquie has previously worked on the design and launch of a compliance & work management IoT service that is in commercial use. She has a BSc in Applied Biology, 10 years’ experience in Molecular Biology and 15 years’ experience of Product Management and Marketing for software, hardware and digital services in medical and life science industries that include immunology, ophthalmology, neuroscience and bioinformatics.

 

Jaquie is a member of the Chartered Institute of Marketing (CIM).

DR. FREDERIC DAYAN

CEO
ExactCure

DR. FREDERIC DAYAN

CEO
ExactCure

Frédéric Dayan, 40 years old, is the founder of ExactCure, a company that aims at simulating your personalized response to drugs thanks to digital models. His dream is to build your perfect virtual avatar in a mobile application. Imagine how this virtual copy of yourself could help you optimize your health!
Frédéric is a former Research & Development (R&D) team leader from the Dassault Systèmes software editor. He is expert in modeling for Life Sciences. He received two Doctorates (Pharmaceutical Science + Cancer Research), and a Physics Engineering diploma from the “Ecole de Physique et de Chimie de Paris”.

After an academic career in bio-modeling as a researcher and teacher at the University of Nice Sophia Antipolis, he decided to manage teams in private R&D, both for small and big industries. Now he is creating his own company in order to bring his vision to life: a world where patients and health professionals would benefit from cutting-edge technologies in modeling and simulation.

EYAL TOLEDANO

Co-Founder and CTO
Zebra Medical Vision

EYAL TOLEDANO

Co-Founder and CTO
Zebra Medical Vision

Eyal Toledano is co-founder and CTO of Zebra Medical Vision; Eyal focuses on innovation in medical imaging machine vision. Graduated with Master of Science from the MIT Media Lab. Eyal served for more than 8 years as the CTO and Advanced Technology GM for Samsung Israel R&D (STRI/Yakum). Before co-founding the Israeli R&D of Samsung Eyal was leading the development of challenging projects at Sun Microsystems. Eyal completed 7 years of military service in the IDF Elite Intelligence Technologies. Eyal still hacks code every day and enjoys making morning sandwiches.

MAGNUS CONTEH

Executive Director, Community Health Academy
Last Mile Health

MAGNUS CONTEH

Executive Director, Community Health Academy
Last Mile Health

Magnus Conteh joined the Last Mile Health team in 2018 to help lead the Community Health Academy, which aims to reinvent the education of community health workers – and the health system leaders who support them – for the digital age.

Magnus brings over 25 years of senior level experience in education, global health, and digital health to Last Mile Health. Previously, Magnus worked for seven years at World Vision Ireland, most recently serving as the Deputy CEO/Director of Programmes and Strategy. Notably, he led World Vision’s involvement in the Johnson & Johnson/Janssen Ebola Vaccine trial in Sierra Leone, which included overseeing the deployment of technology critical for the clinical trial. In addition to serving as a member of the World Vision International Digital Health Steering Committee, he forged multi-stakeholder collaboratives and digital health partnerships with a number of governments, mobile network operators, and other INGOs in Africa.Prior to joining World Vision Ireland, he held a number of senior management positions in the National Health Service in the UK and the Health Service Executive in Ireland, where he served as Director for the Regional Centre of Nursing/Midwifery Education at the University Hospital in Galway. Magnus holds a Masters of Health Science (Hons) in Health Services Research from the National University of Ireland, Masters of Arts in Health Service Policy and Management from Brunel University (UK), and a Postgraduate Diploma in Management Studies from Kingston Business School at Kingston University (UK).

MARTIN CIUPA

Chief AI Officer
Mindmaze

MARTIN CIUPA

Chief AI Officer
Mindmaze

Martin Ciupa currently works at Mindmaze as Head of AI Initiatives / CAIO, based out of their HQ (Lausanne, Switzerland). He has worked as a senior manager in AI/Cybernetic & Robotic systems and IT&T solutions based primarily in Europe, the Americas and Asia. These roles encompassed both technology and commercial roles at an executive level, e.g., Regional VP for Agilent and British Telecom. His most recent position was CTO of Calvary Robotics Software Division (calvIO), developing intelligent automation systems. Academic background: Physics and Cybernetics, and has been published in international journals and conference proceedings, including in the past year presentations to the EU, Keynote address to the Robotics Industry Association, Boston Harvard Medical School/Forward Leading Big Data & AI conference, the Berlin “Rise of AI conference” and the United Nations SDG Health Summit. The Agilience Authority Index has rated Martin as a top 100 authority in AI, ML, Speech Recognition and NLP. Thomson Reuters rates Martin in the top 25 of social influencers in Risk, Compliance, and RegTech in the United States. You can check him out further on his well viewed TEDx, and social media where he has more than 80k followers.

FRANK HESTER

Founder and CEO
The Phoenix Partnership

FRANK HESTER

Founder and CEO
The Phoenix Partnership

Frank has always been at the forefront of IT innovation. In his early career he was instrumental in building technological infrastructure in the finance industry. Frank founded TPP in 1997 and pioneered integrated care – delivering his vision of connected care across all health settings. Today, TPP provides leading software that is transforming healthcare worldwide. Frank is active in all aspects of the company’s business operations, working alongside the teams in the development of TPP’s products and representing the company in the public domain.
Frank’s innovative vision is nationally recognised by the NHS, leading journals and healthcare organisations. In 2012, he was elected to the board of TechUK as a spokesperson for the healthcare IT sector. The following year, he was listed as one of the UK’s top 50 innovators in the national health publication, HSJ. In 2015, Frank was named on the Queen’s New Year’s Honours List to be awarded with an OBE (Order of the British Empire), for his services to healthcare.
Frank has been invited on numerous government trade missions, representing the UK health industry around the world. He has visited countries such as China, India and Brazil as part of trade missions led by British Prime Minister, David Cameron and by Kenneth Clarke, QC, MP.

AMIR BANIFATEMI

General Manager - Innovation and Growth
XPRIZE

AMIR BANIFATEMI

General Manager - Innovation and Growth
XPRIZE

Prior to joining XPRIZE, Mr. Banifatemi began his career at the European Space Agency and then held executive positions at Airbus, AP-HP and the European Commission division for information society and media. He managed two venture capital funds and contributed to the formation of more than 10 startups with emphasis on Predictive Technologies, IoT, and Healthcare. Mr. Banifatemi is a guest lecturer and an adjunct MBA professor at UC Berkeley, Chapman University, Claremont McKenna College, UC Irvine, and HEC Paris.
He holds Masters degrees in Electrical Engineering from the University of Technology of Compiègne, a Doctorate in System Design and Cognitive Sciences from the University Paris Descartes, as well as an MBA from HEC Paris.

DR. HUGH STURROCK

Assistant Professor of Epidemiology & Biostatistics
University of California San Francisco (UCSF)

DR. HUGH STURROCK

Assistant Professor of Epidemiology & Biostatistics
University of California San Francisco (UCSF)

Dr. Hugh Sturrock is an Associate Professor of Epidemiology and Biostatistics working in the Malaria Elimination Initiative (MEI) in the UCSF Global Health Group and is lead of the Disease Surveillance And Risk Monitoring (DiSARM) project. Prior to joining the Global Health Group, he completed a MSc in Zoology at the University of Otago, New Zealand studying avian malaria in yellow-eyed penguins and a PhD at the London School of Hygiene and Tropical Medicine, investigating optimal survey methods for Neglected Tropical Diseases and malaria. He has a broad interest in optimizing surveillance methods for tropical infectious diseases, with his research to date involving a combination of field work and statistical analyses. He is particularly interested in the use of statistics, machine learning, mapping and digital technology to help solve problems facing disease programs. He has worked in a number of countries, including Kenya, South Sudan, Yemen, Namibia and Swaziland.

Hugh also teaches and mentors students at UCSF, is course director for a new online Spatial Epidemiology course at UC Berkeley and has served as co-supervisor for students at the University of Namibia. He also serves as an advisor for the Global Health Corps, supporting fellows placed in public health programs throughout Africa.

Hugh’s work has been featured in numerous peer-reviewed publications as well in media articles in The Guardian, BBC, New York Times and the San Francisco Chronicle. Hugh and the DiSARM project were also featured on a PBS Newshour segment.

DR DARREN GATES

Paediatric Intensivist and Innovation Consultant
Alder Hey Children’s Hospital

DR DARREN GATES

Paediatric Intensivist and Innovation Consultant
Alder Hey Children’s Hospital

Dr. Darren Gates is a senior Registrar in Paediatric Intensive Care at Alder Hey Children’s Hospital, Liverpool, UK. In addition to his clinical practice he works as a Clinical Innovation Consultant in the Trust’s award-winning Innovation Hub where he is clinical lead for the artificial intelligence workstream. This includes The Living Hospital project, a partnership with the Science and Technology Foundation Council’s (STFC) Hartree Centre and IBM, working to improve patient care and experience.

DR JAY PARKINSON

Founder and CEO
Sherpaa

DR JAY PARKINSON

Founder and CEO
Sherpaa

For the past 11 years, Jay has been building services that explore what the internet means to healthcare delivery. Two months after the iPhone was released back in 2007, he launched the world’s first mobile-powered house call doctor practice and it subsequently went viral racking up 7 million hits on his site in the first month of operations. Soon after, he co-founded Hello Health, one of the first cloud-based electronic medical records designed to power a new kind of medical practice— one that delivered care both in their offices in NYC and online with their patients. Hello Health continues to thrive powering cutting-edge practices around the world.

In 2010, he co-founded a design firm to work with large brands across the world to help them figure out what the internet means to health. His clients included the NHS in the UK, Sanofi in Paris, Planned Parenthood of America, and Physicians Interactive. With Physicians Interactive, they ideated and designed one of the most popular iPad apps for physicians, Omnio.

In 2012, he created Sherpaa and pioneered Virtual Primary Care. VPC combines the scalability and accessibility of telehealth with the continuity found in traditional primary care and enables primary care doctors to manage 95% of the conditions a traditional office-based primary care doctor can manage. Sherpaa employs full-time physicians and delivers 24/7/365 primary care in 48 states to employees of self-funded companies, members of forward-thinking health plans, and directly to individuals.

DR JON SORENSON

Head of Cheminformatics
Atomwise

DR JON SORENSON

Head of Cheminformatics
Atomwise

Jon Sorenson, Ph.D., is head of the cheminformatics team at Atomwise. Jon has nearly 20 years of experience in computational biology and software leadership, ranging from senior contributor roles to executive management of 100+ person teams spanning computational biology and software operations. He has held senior leadership roles at Applied Biosystems, Pacific Biosciences, Invitae and 10X Genomics, and he is co-author on more than 30 publications and patents. At Atomwise, Jon is thrilled to have returned to his first passion of computational drug design, a field that he first encountered as a college intern working at Merck Research. Before joining industry in 2000, he obtained a Bachelor of Science in chemistry and mathematics from Harvey Mudd College, a Master of Philosophy in theoretical chemistry from the University of Cambridge and a Doctor of Philosophy in computational chemistry from the University of California, Berkeley.

DR OZANAN MEIRELES

Director of the Surgical Artificial Intelligence and Innovation Laboratory
Massachusetts General Hospital

DR OZANAN MEIRELES

Director of the Surgical Artificial Intelligence and Innovation Laboratory
Massachusetts General Hospital

Dr. Ozanan Meireles is a Bariatric, Foregut, and advanced endoluminal Surgeon at the Massachusetts General Hospital, and an Assistant Professor of Surgery at Harvard Medical School. He is the director of the Surgical Artificial Intelligence and Innovation Laboratory (SAIIL) at the Massachusetts General Hospital.

Dr. Meireles graduated from the Sao Paulo State University School of Medicine, in Brazil. He completed his surgical training at Michigan State University and his clinical fellowship in Minimally Invasive and Bariatric Surgery at the University of California San Diego. He spent his research fellowship at the Johns Hopkins Hospital investigating augmented reality in surgery and robotic telemanipulation. Furthermore, he was deeply involved in studying and developing Natural Orifices Trans Endoluminal Surgery (NOTES) techniques, and he was among the first to pioneer their clinical applications.

At SAIIL, his research focus is on utilizing computer vision to investigate the intraoperative phase of care through real-time, automated surgical analysis, and provide surgeons with additional data, with the goals of democratization of surgical knowledge, lowering costs, improve patient outcomes, and reduction of morbidity and mortality.

He is a fellow of the American College of Surgeons (ACS) and the American Society for Metabolic and Bariatric Surgery (ASMBS). He serves as the Chairman of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Artificial Intelligence Task Force. He also holds key leadership positions and committee memberships in several other national societies in the United States, including the ACS, NOSCAR, ASMBS, and SSAT.

JENNY BARNETT

Chief Scientific Officer
Cambridge Cognition

JENNY BARNETT

Chief Scientific Officer
Cambridge Cognition

Named one of the 40 most influential Healthcare Technology Transformers in 2017, Jenny is responsible for ensuring that all our neuroscience products and services meet the highest scientific standards, as well as the practical needs of researchers, doctors and patients.  Jenny joined Cambridge Cognition in 2008 and has worked in a variety of roles across the clinical trials and healthcare arms of the business. She led research and development activities for groundbreaking products such as CANTAB Mobile, an iPad-based medical device used to test for the first signs of Alzheimer’s disease, and Cognition Kit, a mobile and wearables platform for the remote monitoring of brain health.

Jenny has an MA in Experimental Psychology from Oxford University, a PhD in psychiatric epidemiology from the University of Cambridge, and completed post-doctoral work at Massachusetts General Hospital and the Broad Institute of Harvard and MIT. She is an Honorary Research Fellow at the University of Cambridge Department of Psychiatry, a team member of the Oulu University, Northern Finland Birth Cohorts, and the author of more than 50 academic publications covering topics ranging from psychology and neuroscience to genetics and health economics.

ANDRE ESTEVA

Head of Medical AI
Salesforce Research

ANDRE ESTEVA

Head of Medical AI
Salesforce Research

Andre Esteva is a researcher and entrepreneur in deep learning and computer vision. He currently serves as Head of Medical AI at Salesforce Research. 

He obtained his PhD in Artificial Intelligence at Stanford, advised by Sebastian Thrun and co-advised by Stephen Boyd. His research was in deep learning and computer vision, with applications built for dermatology, drug screening, neuroscience, and psychiatry. 

Notably, his work showed that computer vision algorithms could match the performance of dermatologists at classifying skin cancer from images. His work has made the cover of Nature, as well as Cell, Nature Medicine, NeurIPS, and other venues. It has been widely covered by the WSJ, Fortune, BBC, The Economist, and similar news outlets. He interned at Google Research, Sandia National Labs, and GE Healthcare. 

He finished undergraduate degrees with highest honors in Electrical Engineering and Pure Math from UT-Austin and was awarded Engineering Valedictorian (formally, the Outstanding Scholar-Leader Award). 

NENEH SALLAH
Medical Research Scientist
UCL Institute of Health Informatics
         
 
NENEH SALLAH
Medical Research Scientist
UCL Institute of Health Informatics
         
 
RAMATOULIE JALLOW
Connector and Administrator
Pan African Women in Health
         
 
RAMATOULIE JALLOW
Connector and Administrator
Pan African Women in Health
         
 

Ramatoulie is a Public Health Consultant and Health Communications Specialist. She holds an MPH in Community Health Promotion, with an interdisciplinary concentration in Global Health, from the University of Minnesota, USA. Ramatoulie is a Connector and Administrator for the Pan African Women in Health (PAWH) virtual platform which creates a space for African women health professionals to connect and provide or receive mentorship.

Presently, she works as a Stigma Index Researcher with the Global Network for People living with HIV (GNP+). Previously, she served as an Epidemiologist, with the US Centers for Disease Control and Prevention, conducting surveillance of the West Africa Ebola outbreak in Guinea and providing technical assistance to the Ministry of Health and to the Expanded Program of Immunization’s supplemental immunization activities for polio eradication. Prior to joining CDC, she conducted HIV/AIDS research in Kigali, Rwanda, as a Global Health Corps fellow, and worked as an HIV/AIDS Medical Case Manager in Minnesota, USA. As a Consultant, she has worked on a variety of projects related to women’s empowerment and the demographic dividend in the Sahel as well as on youth access projects and family planning services in Senegal. Ramatoulie is an avid mentor and an advocate for girls and women’s sexual and reproductive health rights. She is also a member of Scientists of the Gambia, Paradise Foundation’s COVID-19 Coordination team, and EyeToo; initiatives founded by young Gambians, both in the diaspora and at home, to encourage more youth to pursue STEM careers, improve health messaging around COVID-19, and to address accessibility and affordability of vision care in The Gambia, respectively. She is presently based in Yaoundé, Cameroon.

DR. HELMI ZAKARIAH
CEO
AIME Artificial Intelligence in Medical Epidemiology
         
 
DR. HELMI ZAKARIAH
CEO
AIME Artificial Intelligence in Medical Epidemiology
         
 

Dr Helmi Zakariah (MD, MPH) is currently the CEO of AIME and AI4Good, and a member of the WHO/ITU Working Group for AI in Outbreak. When the Covid19 pandemic reached Malaysia, he was tasked to lead the Digital Epidemiology portfolio for the Selangor State Task Force for Covid19 – the most densely populated state in Malaysia, where he pioneered the nation’s first e-tracing ecosystem and IRC (Inherent Risk of Contagion) Modelling for outbreak containment.

He regularly share his thought in global health platform such as the Chatham House, World Economic Forum, and Commonwealth Digital Health Forum.

CAROLINE NOUBLANCHE
CEO
Apricity
         
 
CAROLINE NOUBLANCHE
CEO
Apricity
         
 

Caroline Noublanche is the founder and CEO of UK virtual fertility clinic, Apricity, and an experienced entrepreneur.

At age 27, Caroline co-founded mobile applications firm Prylos. She sold it to Swedish telecoms giant Doro AB in 2011, where she became vice president. More recently, she joined the AXA-backed incubator Kamet Ventures as an ‘entrepreneur in residence’ to help them build and launch disruptive startups in the health tech space.

Caroline recognised that IVF had experienced very little digital transformation in the past 40 years and was an area in need of disruption – this led her to found Apricity, the world’s first virtual fertility clinic, in 2018. Apricity has reimagined the fertility journey by combining technology and artificial intelligence with personalised care and medical expertise. Its digital solution is designed to improve the fertility experience and maximise chances of conception. It achieves this by providing access to world-class fertility advisors and a fully-customised treatment journey for patients, all easily navigated through a mobile app.

JUNAID BAJWA
Chief Medical Scientist
Microsoft Research
         
 
JUNAID BAJWA
Chief Medical Scientist
Microsoft Research
         
 

Junaid is the Chief Medical Scientist at Microsoft Research and a practising physician in the NHS (the UK’s National Health Service). He was previously the Global Lead for Strategic Alliances and Solutions for the Global Digital Centre of Excellence at Merck Sharp & Dohme, where he led a range of strategic initiatives to improve patient care, including establishment of internal partnerships across the enterprise and external partnerships across the health care ecosystem. He cofounded “VelocityHealth” as Europe’s first prevention focused digital-health accelerator, in partnership with Telefonica, and led his team to deliver the “NHS Testbed” in partnership with Verily Life Sciences (part of Alphabet), which the Health Service Journal recognized as the “Best Pharmaceutical Partnership with the NHS” in 2018.

Previously, Junaid has worked across primary care, secondary care, and public health settings in addition to acting as a payer, and policy maker within the UK, where he specialized in informatics, digital transformation, and leadership. He has consulted for health care systems across the US, Australia, New Zealand, Singapore, and Europe, in addition to being seconded by the NHS to work with IBM. Junaid completed his MBA at the Imperial College Business School in London and has studied health strategy and quality improvement at both Harvard and the Institute of Healthcare Improvement in Boston. Academically, he is a Clinical Associate Professor at UCL (University College London), and Visiting Scientist at the Harvard School of Public Health.

Junaid hopes to bring his clinical, life sciences, and academic experiences together in this new role. He hopes to help healthcare focused teams across Microsoft, unlock the power of technology to help solve the healthcare challenges of today, whilst reimagining a better future for tomorrow.

 

CAITLIN PLEY
Policy Associate
Women in Global Health
         
 
CAITLIN PLEY
Policy Associate
Women in Global Health
         
 

Caitlin Pley is a policy associate with Women in Global Health and specialises in Universal Health Coverage. Together with colleagues from Women in Global Health and the Alliance for Gender Equality and UHC, she has advocated for gender equality in the health workforce and the inclusion of essential sexual and reproductive health services in UHC. Caitlin has a broad range of experience in global health, having worked on access to medicines with Médecins Sans Frontières, antimicrobial resistance with Public Health England, and palliative care policy with Chatham House. She is currently pursuing a medical degree from the University of Cambridge, where she also teaches pharmacology.

Interested in speaking at the event?

Please nominate yourself via the form below

Become a speaker